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Quantitationa b s t r a c t
Metabolomics analysis of body fluids as well as cells is depended on many factors. While several well-
accepted standard operating procedures for the analysis of body fluids are available, the NMR based
quantitative analysis of cellular metabolites is less well standardized. Experimental designs depend on
the cell type, the quenching protocol and the applied post-acquisition workflow. Here, we provide a
tutorial for the quantitative description of the metabolic phenotype of mammalian cells using NMR
spectroscopy. We discuss all key steps of the process, starting from the selection of the appropriate
culture medium, quenching techniques to arrest metabolism in a reproducible manner, the extraction of
the intracellular components and the profiling of the culture medium. NMR data acquisition and
methods for both qualitative and quantitative analysis are also provided. The suggested methods cover
experiments for adherent cells and cells in suspension. We ultimately describe the application of the
discussed workflow to a thyroid cancer cell line. Although this tutorial focuses on mammalian cells, the
given guidelines and procedures may be adjusted for the analysis of other cell types.
© 2017 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Contents
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In vitro cell based metabolomics studies, often combined with
other eomics, have found widespread use in many areas of
research. These include: studies on the effect, action and toxicology
of drugs [1,2], characterization and understanding of cancer cell
metabolism [3], regenerative medicine [4,5], immune metabolism
[6,7] and many more. The common goal of all of them is to un-
derstand and decipher the influence and involvement of meta-
bolism on/in biological effects and mechanisms, and integrate this
information onto metabolic maps [8]. When working with cellular
systems, detailed quantitative metabolic data is required for both
the intra- and extra-cellular compartment. In recent years, several
targeted metabolomics approaches have been developed in order
to obtain such quantitative metabolic data, including mass spec-
trometry (MS) and NMR based methods [9e22]. Particularly MS
based approaches are jeopardized by ionization suppression, ma-
trix effects and linearity issues, of which some have been overcome
by global internal standard methods such as the MIRACLE approach
[21,23]. On the other hand, NMR spectroscopy is much less sensitive
when compared to MS based techniques. Nevertheless, firstly,
many core metabolites needed for constructing metabolic maps
(i.e. amino acids, sugars, TCA cycle intermediates) are present at
levels which can be analysed using NMR spectroscopy. Secondly,
NMR is a non-destructive and much more robust technique when
compared toMS and thirdly, quantitation using NMR can be carried
out in a straightforward manner without the need for specific in-
ternal standards spanning as much as six orders of magnitude. In
summary, NMR is a robust, quantitative technique which can be
used to analyse several core features of cellular metabolism. There
are two options to measure cellular metabolism using NMR, either
using intact cells and high resolution magic angle spinning (HR-
MAS) NMR [24], or using extracts reconstituted in a solution sam-
ple. The first option, although useful, requires special equipment
and is beyond the scope of this tutorial. Instead, here we present a
detailed step by step tutorial on how to use NMR for obtainingquantitative cellular metabolic data for more than 65 key metab-
olites from several chemical classes.
2. Sampling of cells and culture media
The overall enzymatic activity within cells is sensitive to the
extracellular environment, and specifically to the availability of
substrates, the pH and the local temperature. Therefore, the choice
of culture medium and the growth environment is a critical step in
the experimental design. First, cells need to be cultured under
standardized conditions, optimized for the needs of the study and
able to provide reproducible cellular phenotypes between batches
of cell lines [25]. Second, as cell culture conditions can vary greatly
between different cell types, care has to be taken that none of the
medium components compromises the quality of the metabolic
profiling with the selected analytical platform. The next step of the
sampling process, and often the most difficult one, is the selection
and optimization of a quenching method that produces reproduc-
ible and valid screenshots of intracellular metabolism. The com-
ponents of the latter have to be extracted quantitatively with a
method that provides high metabolic recovery. Most often, it is
desirable to collect data from both, the extra- and intra-cellular
compartment- and the separation of both is required prior to or
during the quenching step. This process may vastly depend on
whether the cells are in suspension or adherent. There is a plethora
of methods proposed for the sampling of mammalian cells [26] and
in the following sections we discuss the most suited ones and
provide some practical guidelines for their facile implementation.
The general outline of the proposed workflow is depicted in Fig. 1.
2.1. Culture medium selection
There is a broad range of synthetic culture media, with opti-
mized formulations to fulfil the growth needs of a wide range of
cells. However, the culture environment is influenced by the
presence and levels of a number of factors [25]. These are: essential
Fig. 1. Schematic workflow diagram for the presented NMR-based targeted profiling of cell culture medium and intracellular metabolites from adherent and in suspension
mammalian cells.
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mones, gases (O2 and CO2) and a regulated environment (pH and
temperature). The proper choice of a culture medium is based on
the type of cells, with Dulbecco'sModified Eagle's Medium (DMEM)
and Roswell Park Memorial Institute (RPMI) being the most
frequently used media for a wide range of mammalian cells.
However, also other types of medium as for example keratinocyte
growth medium (known as KGM) were successfully analysed with
the described protocol. In general, any type of standardmammalian
cell medium should be analysable with the here described method.
We however recommend to double check this, by analysing me-
dium samples and comparing the obtained quantitative results
with the supplier's specifications. Growth factors and hormones are
usually supplied either as isolated serum components or by the
addition of Fetal Bovine Serum (FBS) to the medium, in the range of
2%e10%. Stable pH, typically at neutral values (~7.4), is maintained
by the addition of sodium bicarbonate (NaHCO3) and the supply of
5e10% gaseous CO2 in the incubator. In order to keep pH stable
when CO2 supply is not possible (e.g. outside the incubator) it is
typical for media to include 4-(2-hydroxyethyl)-1-piperazine
ethanesulfonic acid (HEPES). While HEPES has a superior buff-
ering capacity compared to NaHCO3, it is very problematic for NMR-
based metabolic profiling as it is usually present in high concen-
trations (25 mM in DMEM) and its broad and intense resonances
are overlapping with those from several metabolites of interest
(Fig. 2). Therefore, if possible, HEPES should be avoided and extra
care should be taken for fast handling of samples when placed
outside the incubator, to avoid pH variation before quenching.
Another common reagent used in culture media is the pH in-
dicator phenolsulfophthalein (phenol red). It is typically found in
the range of ~25e40 mM and contributes two peaks in the aromatic
region of the proton NMR spectrum at d 6.62 and 7.37 ppm (at
pH ¼ 7.4). These peaks have a rather low intensity and appear at a
less crowded spectral region and thus their presence is notFig. 2. 1D 1H NMR spectra of intracellular metabolites from cells cultured in a mediumwith (
intense resonances of HEPES (A).hampering the quantitation of other compounds. None of the other
components commonly used in culture media cause any problems
associated to data quality, at least with regard to NMR analysis,
except for intact FBS or isolated serum components for which a
protein precipitation step is needed (cf section 2.2).2.2. Sampling of culture medium
In the case of adherent cell cultures, collection of medium is
straightforward and can be done at several time points during the
growth period without affecting the cells. For NMR-based studies,
about 50e300 mL are directly collected from the culture plate using
a pipette. However, it should subsequently be secured that the
remainingmediumvolume is not becoming a limiting factor, in that
cell growth or metabolism might be affected. In our lab, cells are
usually cultured in approximately 6e10 mL of medium fromwhich
a maximum of 0.3 mL is collected for analysis. However, in case of
cells growing in suspension, there is no reliable manner to collect
culture medium without affecting the state of the cells. Still an
option can bewhen, either thewhole culture broth or a portion of it
is collected and separation of cells from the culture medium is
rapidly performed by filtration or centrifugation. Filtration has the
advantage that it can be carried out in a few seconds by immedi-
ately passing a small quantity of the culture broth through sterile
syringe filters with 3 kDa cut-off membranes. The pore size of the
filters depends on the size and the number of cells, since too many
cells can block the filters and reduce the recovery of the medium
[27,28]. Pore sizes ranging from 0.2 to 5 mm have been used
[27,29,30] and a study specific evaluation is necessary for the
proper selection of filters. Another critical issue when using filters
is to remove membrane additives, e.g. glycerol on cellulose filters,
which can contaminate the filtrate. We recommend thorough
washing of the filters with phosphate buffered saline (PBS) or 0.9%
(w/v) NaCl solutions at room temperature prior to usage andA) or without HEPES (B). Several metabolites shown in (B) are masked by the broad and
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Applying centrifugation as a method to separate extracellular
from intracellular metabolites, has the disadvantage of being rather
slow, possibly leading to a skewing of intracellular metabolism. On
the other hand, it has the advantage that a high number of cells can
be sampled in contrast to filtration. If only the exometabolome is
analysed, and fast filtration is not an option, a mild centrifugation
(<1000g) at 4 C or lower (down to 20 C) for 1 min should be
sufficient to separate cells from medium. Unfortunately, in this
case, leakage of intracellular components cannot be excluded.
Centrifugation is generally preferred when both intracellular and
the extracellular metabolites are to be analysed from the same
sample and a high number of cells per sample is employed. For this
purpose, separation of the cells from the culture medium and
quenching are performed simultaneously, a topic that will be
covered in the following section 2.3.
Regardless of the method used for collection, the culture me-
dium samples should be processed immediately with an organic
solvent to remove proteins (intact FBS or serum isolated macro-
molecules) and immediately quench any possible residual meta-
bolism. Macromolecules can induce errors [31] in the subsequent
NMR analysis for two reasons. First, metabolites might become
non-specifically bound to proteins thus altering the sample's
observed metabolic composition. Second, protons from macro-
molecules as well as those from their weakly bound ligands (me-
tabolites) appear as broad resonances in the NMR spectrum due to
their shorter transverse relaxation (T2 relaxation time) compared
to small molecules. This ultimately compromises data quality and
induces laborious processing steps (e.g. correction of baseline) and
analytical errors due to broadened peak shapes (e.g. complex
deconvolution of overlapped peaks, inaccurate fitting of peaks,
etc.). Although, broad peaks from macromolecules can be techni-
cally attenuated by performing T2-filtered NMR experiments, like
the Carr-Purcell-Meiboom-Gill (CPMG), the NMR intensities from
other metabolites will also be partially affected due to small dif-
ferences in T2 times, and thus their absolute quantitation will not
be possible [32]. Protein precipitation of samples is therefore rec-
ommended. In most cases either cold methanol or acetonitrile
[28,32] for macromolecule precipitation are used. In our laboratory,
we routinely mix one volume of culture mediumwith two volumes
of 100% LC-grade cold methanol (left overnight at 80 C and then
placed on dry-ice for a short time during sample collection) in a
microcentrifuge tube and allow the proteins to precipitate at
e20 C for 30min followed by centrifugation at 16000g at 4 C for
20 min. The supernatant is then collected and stored at 80 C, or
immediately dried to remove the methanol for subsequent NMR
measurements.
2.3. Quenching of intracellular metabolism
Some intracellular metabolites present very fast turnover rates,
such as ATP (1.5 mM/s), ADP (2.0 mM/s) and D-glucose (1.0 mM/s)
[33,34]. Hence, prolonged sampling times may induce variations in
the intracellular metabolome. Therefore, an immediate and effec-
tive quenching step is required, in order to obtain an accurate and
reproducible description of the cellular phenotype. Today's most
common methods for quenching include the use of cold organic
solvents [20,35e37], cold isotonic solutions [17,27], or liquid ni-
trogen [38]. Often, a washing step is additionally performed to
remove residual culture medium from the cells [17,20,37,38]. The
selection of the right method is dependent onwhether the cells are
growing in suspension or attached to the plate wall. A careful
evaluation and optimization should always be performed to match
the study specific experimental design. A critical overview of the
best suited protocols is provided in the following sections 2.3.1 to2.3.3 together with practical recommendations.
2.3.1. Quenching of cells in suspension
A critical aspect of quenching with cold organic solvents and in
particular methanol, is the reported membrane leakage and loss of
intracellular components [27,39]. Two methods have been sug-
gested to solve this problem, both tested with Chinese hamster
ovary (CHO) cells. The first includes the addition of 0.85% (w/v)
ammonium bicarbonate (AMBIC) as a buffering system (pH 7.4) in a
cold methanol solution methanol/AMBIC 6:4 (v/v) at 40 C)
[35,39]. Quenching was performed by mixing one volume of sus-
pension cultured cells (~1  107 cells) and 5 vol of quenching so-
lution followed by centrifugation for 1 min at 1000g at 20 C.
The supernatant (quenching solution) was then removed and
0.5 mL of cold 100% methanol (80 C) was added to the cell pellet
and themix was snap frozen in liquid nitrogen and stored at80 C
until extraction. The critical steps of this method are, i) to maintain
the quenching solution at 40 C but not colder than 45 C, in
order to avoid membrane leakage and ii), to perform a mild
centrifugation at 20 C for no longer than 1 min. An adjustment
could be made to the duration of centrifugation, if for example the
available instrument cannot operate at 20 C, shorter times
should be evaluated in order to ensure the temperature remains
low [40] while still managing to separate the cell pellet.
In the second method, the use of an isotonic aqueous solution
(0.9% (w/v) NaCl at 0.5 C) instead of methanol is proposed for
quenching [27]. In this study, one volume of suspension cultured
cells was mixed with four volumes of 0.9% (w/v) NaCl and centri-
fuged at 1000g for 1min at 0 C. The cell pellet was then placed on
ice for a maximum of 10 min until extraction. However, in our
experience, it can also be frozen and stored at 80 C or on dry-ice
until extraction if more time is required. This method appears to be
less laborious, e.g. there is no need for narrow temperature control
at 40 C. However, both studies [27,39] have used the same cell
line (CHO cells) but failed to reproduce exactly the same results
after comparison of the twomethods [27,35]. At the moment, there
isn't any definite answer found in literature concerning the most
suited method for quenching suspension cells and in most cases,
adaptations of the above mentioned methods are needed [26].
Ideally the ultimate choice should rely on some study specific
quality assurance criteria which are discussed below in section
2.3.3.
2.3.2. Quenching of adherent cells
Adherent mammalian cell metabolism can be quenched with
either cold organic solvents [20,37], cold buffer solutions [17] or
liquid nitrogen (lN2) [38]. While themajority of the culturemedium
is easily removed by aspiration, unfortunately some traces will
remain in the dish. Since many intracellular metabolites are also
present in the culture medium, incomplete removal will quantita-
tively affect the obtained data for intracellular metabolites. There-
fore, one or two rinsing steps are performed with either ice-cold
PBS [20], ice-cold saline solution (0.9% NaCl (v/v)) [17], warm PBS
(37 C) [37], or warm deionised water (37 C) [38]. Washing with
cold PBS or saline solution has the advantage that metabolism is
slowed down due to the low temperature obtained and therefore
provides a time window needed to add the quenching solution. On
the other hand, applying a cold shock to the cells might increase the
risk of membrane leakage and loss of intracellular metabolites.
From this point of view, washing with a solution at the same
temperature as the culturemedium, reduces the cold shock, but has
to be performed quickly enough (in less than 5 s) to minimize
turnover of labile metabolites. While direct comparison of warm
PBS with warm deionised H2O resulted in higher metabolic re-
covery for cells washed with water [38], the very low ionic strength
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brane integrity [41]. PBS on the other hand is a balanced osmotic
salt solution and is well suited for short term cell storage. From our
experience, rinsing cells once with warm PBS (in 3e5 s) is sufficient
for complete removal of culture medium prior to quenching.
While quenching with cold organic solvents or buffers are
feasible techniques, the choice of lN2 is the quickest, most simple
and effective method [38]. As soon as the culture medium is
completely removed, there is no need to maintain cellular mem-
brane integrity. On the contrary, snap freezing with lN2 aids the
subsequent extraction step by inducing some damage to the cell
membranes and thus increasing metabolite extraction efficiency.
However, since lN2 is quickly evaporated, it is critical that cells are
not allowed to thaw until the extraction step. This is easily achieved
by keeping the dishes on dry-ice until all samples are processed. For
a culture dish with a diameter of 10 cm, about 5mL of warm PBS are
needed for washing and 10 mL lN2 for quenching.
2.3.3. Design and evaluation of optimal quenching conditions
As it was discussed in section 2.3.1, the selection of the optimum
quenching protocol for cultured cells in suspension is often a study
specific question and there is some confusion about what method
to follow. In our opinion, an optimal outcome can be obtained
when, evaluation experiments using either one of the suggested
methods as the basis are performed. Subsequently small adapta-
tions to themethod of choice should be applied until the demanded
quality parameters are fulfilled, i.e. effective quenching of meta-
bolism and no (or at least minimal) membrane leakage. Firstly,
cellular membrane integrity during quenching should be evaluated
by analysing both, intracellular and extracellular metabolites and
comparing their levels with control culture medium (cell-free) as
well as culture medium from unquenched cells. Two sets of me-
tabolites can be used as measures for membrane integrity. The first
set consists of labile molecules, like ATP, ADP, AMP, NADH and
NADþ. These metabolites are typically found inside the cell, and
their identification in the medium is an indication of a disrupted
membrane. This set of metabolites can also be measured by enzy-
matic assays. The second set of metabolites are the tricarboxylic
acid intermediates, citrate, succinate, malate and a-ketoglutarate
(oxaloacetate can be confused with pyruvate in the proton NMR
and should therefore be avoided here), which are indicators of
membrane leakage [35]. We recommend evaluation of the levels of
these two sets of compounds in the intracellular extract, the culture
medium after quenching and the medium from unquenched sam-
ples. Direct comparison of recoveries in each of the quenching
methods used, as well as the presence of the labile compounds in
the mediumwill provide the basis for choosing the best quenching
method with regard to membrane integrity. In those cases that
membrane leakage is found for all suggested methods described
here, additional adaptations are needed, specifically investigating
centrifugation time and g-force, as well as temperature and in-
crease of ionic strength of the applied quenching solution.
Secondly, quenching efficiency should be investigated (for both
adherent and suspension cells) using the adenylate energy charge
(AEC) as an estimation [42]. This is done employing the following
equation: AEC ¼ (([ATP] þ [ADP]/2)/([ATP þ [ADP] þ[AMP])) and
provides a good readout of the cells state after quenching. Actively
metabolizing cells exhibit a high excess of energy-rich adenylate
phosphate resulting in high AEC values (0.80e0.95) after quench-
ing, indicating an effective quench of metabolism. ATP, ADP and
AMP can be evaluated by commercial assay kits.
A final critical issue of the quenching procedure that should be
noted is the often-underestimated issue, of maintaining the
quenched state until extraction has occurred. Typically, the entire
experiment includes the quenching of several samples, hence aconsiderable time interval until extraction has to be taken into
account, during which the temperature of the quenched cells has to
remain low (<-50 C). Moreover, it has to be considered that the
temperature of the quenching solution increases when added to a
plate or tube with cells being at 37 C. Therefore, if for example, ice-
cold saline solution is used, a slight increase of temperature is
initially expected, which cannot be circumvented by placing the
samples on ice. A study using the model microorganism Coryne-
bacterium glutamicum, quenching with 60% (v/v) methanol
at 50 C, has shown extensive labelling of intracellular metabo-
lites upon addition of uniformly 13C-labelled D-glucose to the
quenchedmixture. After evaluation of the mixture's temperature, it
was found that this activity occurred at 20 C but not at 50 C
(quenching temperature) or at 80 C (upon sample storage) [40].
It is therefore, strongly suggested that quenched samples are snap-
frozen in lN2 and temporarily stored 80 C or kept in a box with
dry-ice until extraction to avoid any post-quenching skewing of
metabolism.
2.4. Extraction of intracellular metabolites
Several methods have been evaluated for their performance in
extracting intracellular metabolites. The majority concluding that
the use of organic solvents and their aqueous mixtures are the best
option. Unfortunately, there remains much confusion about which
exact solvent and mixture to use, furthermore considering polarity,
temperatures and extraction cycles. For instance, ice-cold 50% (v/v)
aqueous acetonitrile [27], 82% (v/v) ice-cold aqueous methanol
[20], pure methanol [17,43] and 90% (v/v) 9:1 aqueous methanol/
chloroform [12,38] have all been evaluated and described as best
extraction solutions after quenching. On the other hand, 70% (v/v)
ice-cold aqueous acetonitrile [37], and ice-cold 80% (v/v) aqueous
methanol [44] have been proposed to perform quenching and
extraction in a single step. However, the inhomogeneity of the
intracellular metabolites, the various cell lines and the different
analytical methods used in the described studies might explain the
different outcomes. In turn, extraction should be evaluated indi-
vidually per researcher per study.
Also, it should be kept in mind that, except for good metabolite
recoveries, protein and macromolecule precipitation are important
characteristics of extraction solutions. In our experience the
aqueous solutions of acetonitrile (ACN), methanol (MeOH) and
methanol/chloroform (MC) mentioned above, all fulfill these
criteria, however, only forMC, a systematic evaluation of the degree
of polarity is described in literature [38]. It was found that a ratio of
90% (v/v) aqueous MeOH/CHCl3 9:1 (MeOH/CHCl3/H2O (v/v/v),
8.1:0.9:1) results in approximately 75% (v/v) aqueous MeOH/CHCl3
9:1 when the residual water in the 10 cm culture dish is taken into
account (~0.3 mL). For this condition, the extraction resulted in
highest recovery for a broad range of metabolites [38], while
effectively removing intracellular macromolecules. However, and
as the authors suggest, they achieved similar results with a 70% (v/
v) MeOH solution but with slightly less stable extracts. In our lab,
we have successfully implemented the 90% MC extraction with an
adherent cell line, as we outline in the last part of this tutorial
(Section 5).
The temperature of the extraction process is another critical
aspect. We have already discussed in 2.3.3 that some enzymatic
activity occurs after quenching if the temperature is not low
enough. The same is known to occur even after extraction of the
intracellular metabolites, probably due to incomplete removal of
proteins or chemical interconversion of metabolites in the extract
[38,45]. Based on our experience, keeping the sample temperature
as low as possible throughout the whole process from post-
quenching to extraction and cell pellet removal, is an important
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suggest keeping dishes or tubes always on dry-ice during sampling
and using a 80 C extraction solution (MeOH/CHCl3 or aqueous
MeOH). The centrifugation step for the separation of the extract
from the cell debris should also be carried out at the lowest possible
temperature. We have obtained highly reproducible results with
centrifugation at 16000g and 4 C for 15 min.
Finally, it has been shown that repeated extraction cycles using
the same solvent system as initially applied helps in increasing
metabolite recovery [35,43]. In addition, methods that increase cell
membrane disruption like ultra-sonication [46], mechanical ho-
mogenization [20] and freeze-thaw cycles [35] can also increase
metabolite recovery. From our own experience in several cell lines,
repeating the 90% (v/v) MC 9:1 extraction step did not alter total
metabolite recovery, being in agreement with literature [38].
However, when testing ultra-sonication as an additional extraction
step in combination with the MC protocol in murine macrophages,
we observed increasedmetabolites levels. Oncemore, it is apparent
that several tests should be performed to optimize the conditions of
sampling to ensure valid results.
We recommend a multilevel evaluation with a limited number
of biological replicates of the same type of cell lines that will be
used in the study. First, the optimum polarity of the extraction
solvent system should be tested, with regard to protein precipita-
tion and the recovery of the most polar metabolites. The nucleo-
tides and especially the triphosphates (ATP, CTP, GTP) and some
polar amino acids as for example arginine and asparagine together
with some less polar ones like phenylalanine, proline and leucine,
can be used in these tests. We suggest to use 3 different polarities,
starting from 50% (v/v) MeOH (or ACN), to 75% (v/v) aqueous
MeOH/CHCl3 9:1 (or the 70% (v/v) aqueous MeOH) and finally 100%
MeOH. All extraction solvents should be cooled to at least40 C or
lower. The ideal extraction solvent is the one presenting highest
overall recovery with lowest residual protein content. The decision
upon this can be directly taken with a simple and quick one
dimensional (1D) proton NMRmeasurement of these replicates (for
details about the NMR experiment see section 3.2 below). As NMR
is a quantitative method, there is no need for calibration functions
at this point, but rather a straightforward judgement from spectral
overlay should suffice. Protein presence can be easily evaluated by
the intensity of the broad resonance at 0.95e0.85 ppm (methyl
protons). Observation of the internal standard used for chemical
shift and concentration reference is an additional way to decide if
proteins are sufficiently removed. In the absence of non-specific
binding, caused by proteins, the intensity and the linewidth of
the internal standard peak should be identical in all spectra (pro-
vided they are all acquired with exactly the same parameters; see
below sections 2.5 for NMR sample preparation and 3.1e3.3 for
NMR experiments).
Once the optimum polarity is determined, the number of
extraction cycles should be tested with the selected solvent system.
As described above, a second extraction step with 75% (v/v)
aqueous MeOH/CHCl3 9:1 did not add to the recovery of metabo-
lites in our and others experience [38]. However, we do recommend
an evaluation of this step prior to studies where a specific cell type
is being used for the first time. Again, direct comparison of 1D
proton NMR spectra by overlay is the most straightforward method
to quickly evaluate the possible gain of a second extraction step.
Finally, an overall judgement should be made considering
extraction efficiency with regard to the number of metabolites
present in the spectra and the cell numbers or the total biomass of
each sample. Poor spectra, in terms of “compounds detected” and
low signal intensity of some compounds, indicate poor extraction
efficiency. The judgement of the number of compounds detected is
somewhat empirical but in general, one should expect to identifythe vast majority of amino acids, even those that are usually present
in the low micromolar range like tryptophan. On the other hand,
the intensity of the peaks originating from the lactate methyl
protons and/or some cholines likes phosphocholine or glycer-
ophosphocholine should be comparable to the intensity of the in-
ternal standard (see section 2.5 below). If this is not the case, even
after a sustained 1D experiment (e.g. 512 or 1024 scans), this is a
clear indication for poor extraction efficiency. In these instances,
additional extraction measures should be tested. This can be either
ultra-sonication for 30 s or 1 min or 3  freeze-thaw cycles [35,46].
2.5. Sample preparation for NMR analysis
Sample preparation for NMR analysis is typically much less
laborious than the methods described in the previous sections.
Both the culturemedia and the cellular extracts need to be dried for
the removal of the organic solvent(s) used for the quenching and/or
the extraction. Drying can be done either using a SpeedVac or by
applying a stream of nitrogen gas. The procedure typically takes a
few hours (2e3 h), depending on the solvent system. Importantly,
samples should be handled under reduced lighting and contact
with oxygen should be avoided, in order to keep any possible
metabolite degradation as low as possible. Evaporation should be
carefully monitored and samples processed further as soon as
possible.
The dried material is then reconstituted with phosphate buffer
(0.15 M K2HPO4, pH 7.0 or 7.4) in deuterated water (D2O) (~250 mL).
Several key points need to be further addressed here. First, the
regulation of the sample pH with the buffer to a small range either
close to 7.0 or 7.4, ensures minimal or no shifting of NMR reso-
nances across the whole set of monitored analytes, facilitating
quantitative analysis of complex samples. In our studies, we have
obtained excellent reproducibility using 0.15 M K2HPO4 at pH 7.4,
with only minor shifting of, for example, histidine's protons.
However, regulation at pH 7.0 is also acceptable and followed by
others [47]. The second point concerns the selected volume to
reconstitute the dried material. In our laboratory, we routinely use
3 mm NMR tubes and we reconstitute the dried extracts in 250 mL,
however, this volume should be adjusted if other tube sizes (e.g.
5 mmNMR tubes) are to be used. Three mm tubes require 165 mL of
NMR sample volume. The additional volume (up to 250 mL) ensures
that there is enough sample left after tube filling to make a pool
sample for each group of cell extracts (e.g. triplicates from a time
point or from a specific cell line). We highly recommend the
preparation of pool samples for two purposes. First, a pool sample
can be used for the optimization of the spectrometer prior to
automatic measurements (see section 3.1) and second, they can be
used for two-dimensional (2D) NMR experiments and (if needed)
for spiking experiments with reference compounds for metabolites
identification. In the case that more than 3 biological replicates are
used per group, the dried extract can be reconstituted in less than
250 mL of buffer, which will result in even more concentrated
samples and thus increased sensitivity.
Finally, although we use and recommend the use of 3 mm tubes
for studies with cell extracts, clearly the selection of the tube size is
dependent on the available equipment of each laboratory. The
volume needed for the 3 mm tubes is 3.5 times less than the one
needed for the more common 5 mm tubes (560 mL) and thus, a
significant gain in concentration of metabolites in the sample is
achieved. However, as most NMR laboratories are equipped with
5 mm probes, measuring in 3 mm tubes induces a compromise of
the increased thermal noise, which eventually reduces the signal to
noise (S/N) in the recorded spectra. This noise occurs due to a
longer distance between the sample in the probe and the coils used
to apply and record the radiofrequencies (RF) during the NMR
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allowing for the use of 3 mm tubes with less concentrated samples.
However, this gain might not apply in room-temperature probes
and in this case the use of 5 mm tubes should be preferred. Another
option to improve sensitivity, would be to use 1 or 1.7 mm micro-
probes. These probes operate with capillary tubes with diameter of
1 or 1.7 mm, and require just 5 or 30 mL of sample, respectively.
Such significant decrease of sample volume would allow for much
more concentrated samples and thus boost sensitivity. One po-
tential drawback however, could be the sample preparation accu-
racy (i.e. accurate addition of buffer and internal standard). With
such small volumes, the analytical error can be large and detri-
mental for the accuracy of the quantitative analysis.
In contrast to other analytical methods, only one internal stan-
dard is necessary for NMR analysis, being either 3-(trimethylsilyl)-
propionic-d4 acid sodium salt (TSP-d4) or 3-(trimethylsilyl) pro-
panesulfonic-d6 acid sodium salt (DSS-d6). Both compounds can be
used as chemical shift references for the calibration of the NMR
data (at d 0.0 ppm) as well as internal standard for quantitation. It
should be noted however, that in contrast to DSS, TSP is sensitive to
pH and in some cases, it is preferably referenced at d 0.0159 ppm,
with respect to DSS (see section 4.2 for more details). We recom-
mend a concentration of about 0.02 mM of TSP or DSS in the NMR
samples of intracellular metabolites and about 0.2e0.4 mM for
culture medium samples. These concentrations ensure that the
internal standard will have a resonance with sufficient S/N for ac-
curate quantitation and at the same time an intensity within the
average dynamic range of the typically observed components of the
samples. Addition of the buffer and the included internal standard
should be done with the highest possible accuracy. Analytical
variation at this step will induce significant errors if absolute con-
centrations of metabolites are to be determined. Upon addition of
the buffer the samples should be vortexed for 30 s and centrifuged
at ~16000g at 4 C for 15 min to remove any insoluble material.
Supernatants are then transferred to NMR tubes. If possible, a ro-
botic liquid handler can be used at this point for optimal repro-
ducibility of NMR tube filling [48].
As additional step to ensure proper quality of the generated
data, we suggest the preparation of a few quality control samples
(QC) of the same matrix with at least one component of known
concentration added. An easy way to do this is by making aliquots
from a pooled mix of all samples of the intracellular extracts
samples used in the particular experiment or from the culture
medium.While for the latter the preparation is straightforward due
to the excess of the available volume, for the intracellular extracts,
care has to be taken to dissolve the dried material in more volume
than the one require for the NMR tube filling, as described above,
and then prepare some QC samples (at least 2 per 96-well-plate)
from the leftovers. Except for the TSP or DSS, an additional refer-
ence compound (e.g. formate or sodium acetate) can be spiked to
these QC samples, which will be used as a second correction
measure of the quantitative data. All NMR samples should remain
stored at 4e6 C until analysis but no longer than 48 h, as stability
might become an issue.
3. NMR spectroscopy
NMR is used for both structure elucidation and quantitation. It is
considered a robust and quantitative analytical platform, well
known for high reproducibility [49], exhibiting a quantitative in-
accuracy of less than 2% [50]. In order to take full advantage of these
features, both physico-chemical and instrumental parameters need
to be optimized prior to data acquisition. We have already referred
to the pH regulation in the previous section (2.5). Both the pH and
the ionic strength affect the chemical shifts and the relaxationproperties of the protons. Keeping the sample pH within a narrow
range - for cell extracts a pH at 7e7.4 is chosen e results in better
data consistency for both the positions and the intensities of the
peaks across all spectra. Besides sample properties, a number of
other, instrument e related factors can have a significant influence
on the accuracy and precision of the generated NMR data and thus,
they all have to be adjusted and optimized prior to data acquisition
[51]. These parameters are: temperature, homogeneity of the
magnetic field, water signal suppression, tuning and matching of
the probe and the pulse for excitation as well as experimental pa-
rameters like resolution, measurement duration and the sensitivity.
With modern NMR instruments, experiments can be performed in
full automation by loading a pre-optimized set of the above-
mentioned parameters for each sample and applying small ad-
justments for further sample-specific optimization. An overview of
the instrument set up is covered in section 3.1. With quantitative
NMR in mind, some processing of the raw data is also performed to
enhance the appropriateness of the spectra and the latter is eval-
uated by applying several quality criteria. In section 3.2 we provide
some general guidelines to assist the readers implementing these
steps in their own studies.
3.1. NMR spectrometer set up
Prior to any measurements, a calibration of the probe's internal
temperature should be carried out. This is the actual temperature
that every sample will adopt and maintain throughout the whole
experiment. The most commonmethod is to use 99.98% deuterated
methanol in a sealed NMR tube (it is strongly recommended to use
a fresh methanol solution from an ampule) and acquire a short 1H
NMR experiment (~2 scans). The actual sample temperature can be
calculated accurately form the distance (in Hz) between the two
methanol peaks (CH3 and OH) [52]. Appropriate adjustments are
made until an exact temperature of 300 K (27 C) is achieved. All
samples should then be measured at this temperature with an
acceptable deviation range of ±0.02 K. In our system, we have
observed that the sample requires about 3 min in the probe to
adopt to a stable temperature of 300 K. However, we are applying
and strongly recommend, to wait 5 min after each sample is placed
in the probe and before any automatic (or manual) routines are
started, to ensure proper stability of the temperature. If the tem-
perature is not stable beyond 5min the temperature control system
should be tested for malfunction. In some systems, like the Sam-
pleJet form Bruker, there is the possibility to pre-heat the sample
before insertion to the magnet. If such a system is available, then
the sample can adopt the desired temperature faster and the
automation routines can start earlier than the suggested 5 min.
As long as the temperature is calibrated, a standard aqueous
solution is used to optimize the magnetic field homogeneity
(shimming). Improper shimming will result in distorted peak
shapes and reduce the resolution, therefore it will directly affect the
quality of the quantitation [51]. A pooled sample from the study in
progress is an ideal candidate for this step. The optimum shimming
is stored and can be used as the basis for the automatic shimming
routine which is applied to each sample. Since, the stored shim file
is created using the same matrix as the one of all samples in the
study, an on-axis (z-axis) automatic shimming for each sample is
sufficient to provide good homogeneity for the automatic mea-
surements. The shimming quality can be monitored by using the
peak shape of the singlet from the internal standard (TSP or DSS).
The linewidth at half height should not exceed 0.7 Hz.
Although the samples are prepared in D2O (99.98% 2H), there
will be some residual protonated water and its resonance should be
suppressed. This is achieved by a continuous soft pulse (presatu-
ration) with a bandwidth of 25e50 Hz [49] implemented in the 1D
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pression experiment should result in a flat baseline at both sides of
the water resonance and a proper phase of all peaks in the spec-
trum after correction. Although the water suppression efficiency
will probably vary slightly across spectra, this variation will be
negligible for most spectra if an optimization step is performed
before the study measurements. The proper way to do this, is to use
the same pool sample as the one used for shimming optimization
above, and optimize the bandwidth and the irradiation frequency
for water suppression. This can be done by small adjustments of the
water resonance frequency and acquisition of 1D NOESY experi-
ments with 8 scans and all other parameters fixed (delays and
mixing time), until the optimum result is achieved. As a general
rule, we suggest that the width at the baseline of the suppressed
water peak should not exceed 0.15 ppm (~90 Hz in a 600MHz NMR)
when D2O (99.98%) is used as solvent as we propose in this tutorial.
In the case that 10% of D2O is used, then the H2O content is much
higher and an increased bandwidth (50e100 Hz) should be used for
sufficient suppression. One drawback of the presaturation method
however is the partial saturation of the resonances from other
protons in the same region (close to 4.7 ppm). A common example
are the anomeric protons of a- and b-glucose, resonating at d 5.23
and 4.67 ppm, respectively. These resonances will be slightly
reduced and this has to be taken into account for quantification as
we will discuss in section 4.2.1 below. Despite this disadvantage of
presaturation, the robustness of the method, the limited optimi-
zation needed and the ease of automation make it the best method
for studies with biological mixtures [54,55].
Modern NMR spectrometers and probes technology, allow for
automatic tuning and matching of the probe and pulse calibration
for each sample that is inserted into themagnet. Both are depended
on the sample and it's physico-chemical properties as well as the
temperature and their proper calibration is crucial for data con-
sistency. The full set of optimized parameters can be initially ob-
tained using the pooled sample and then used throughout the
whole study with only small per-sample adjustments of tuning,
matching of the probe, shimming and the 90 pulse calibration
[48].
3.2. NMR data acquisition
For cellular extracts and culture media samples, two experi-
ments are performed per sample, a 1D 1H NOESYand a fast 2D 1H J-
resolved (Jres) (Fig. 3). The 1D NOESY provides excellent quantita-
tive spectra with good solvent suppression [53]. The Jres experi-
ment displays the coupling patterns of protons (indirect
dimension) in addition to their chemical shift (direct dimension) in
two dimensions and is very useful for identification of metabolites,
especially in crowded spectral areas [56]. For both experiments, the
optimized presaturation bandwith and frequency is followed, as
determined earlier in the pool sample. In addition to the optimized,
instrumental and experimental parameters, there are also two
additional requirements in order to get accurate quantitative
spectral data with the 1D NOESY. These are, a long enough repeti-
tion time (i.e. the sum of the relaxation delay and the acquisition
time, per scan) to allow the proton nuclei to fully relax after exci-
tation, and sufficient number of data points for high resolution
spectra.
The repetition time is a critical parameter, which in relation to
the longitudinal relaxation time (T1) of the protons, has an
important role for the resonances of the peaks in the spectrum. A
repetition time of about 5 T1 is needed to get 99% relaxed protons
after excitation [49,57]. As a consequence, resonances from protons
with longer 5  T1 than the repetition time used, will exhibit lower
intensities and thus, their concentration cannot be correctlyquantified. In complex mixtures such as those from cell extracts
and culture media, the T1 times vary significantly from a few
hundred milliseconds to some seconds [57]. This practically means
that in order to fulfil the quantitative NMR (qNMR) requirement,
ideally, very long repetition times (30e50 s) should be used. Un-
fortunately, this would not be practical for the analysis of large
samples numbers (typically tens or hundreds, for studies with
mammalian cell lines) hence the use of shorter repetition times is
common in NMR-based metabolomics studies.
Frequently, the comparison of the relative changes of metabo-
lites within a particular study is required. In these cases, the short
repetition times used in the 1D NOESY are not problematic since
the T1 effect on each resonance, will be the same for the same
resonance across all spectra if identical parameters and conditions
are applied. Even when absolute concentrations are to be obtained
(e.g. to compare with the results from other laboratories or
different analytical methods) there are ways to correct the quan-
tification error due to insufficient relaxation time. One way is to
apply a T1 correction factor to each quantified resonance [51,57]. In
order to do so, knowledge of all T1 times is necessary, including the
one of the internal standard used (TSP or DSS). Another option is
provided by the Chenomx NMR suite software (Chenomx Inc.
Edmonton, Canada). If this tool is used for quantification, then it is
possible to extract accurate concentrations without any T1 correc-
tion, while still using a short repetition time of 5 s. The only
requirement is to prepare the sample and acquire the 1D NOESY
experiment in the exact way suggested by the developer. In our
laboratory, we typically use a slightly different set up, optimized for
all our metabolomics analyses [48] with a repetition time of 6.72 s.
In section 4.2 we discuss in more detail about the quantification
methods and corrections with regard to experimental repetition
times.
The spectral resolution requirement is much more straight-
forward and easily achievable in all modern NMR spectrometers.
We suggest to collect 64 k data points in the 1D NOESY to assist a
higher accuracy for quantitation. This amount or raw data
together with a special processing method (zero filling, see
below 3.3) provides high resolution spectra, which facilitate the
quantification and deconvolution of overlapped resonances. For
the interested reader, a detailed description of the experimental
parameters and optimization routines, can be found in the paper
of Dona et al. [48]. Although it is mainly written for application
in body fluids and describes the procedures implemented on
Bruker NMR instruments, with some adaptations the protocols
can be implemented for studies with mammalian cells on any
NMR spectrometer. In section 5 and in the supplementary
information we also provide the experimental parameters we
have used for the analysis of the BHP2-7 cell line on a 14.1 T NMR
instrument. With the exception of the number of scans, which
are depended on sample concentration, all other parameters can
be used by the readers on their own NMR instrumental set up.
Furthermore, we also provide the experimental parameters
suggested by Chenomx and other labs [47] in the supplementary
material.
With regard to experimental times and the number of scans
used per experiment for cellular extracts and culture media, an
evaluation has to be made using the pool sample(s) as represen-
tative measure and also some culture media replicates. The pool
sample (or a sample from a trial experiment prior to the actual
study) provides the right matrix to test for the measurement time
needed. An easy method is to measure the S/N of some resonances,
which exhibit low intensities. This will directly provide the basis of
how many scans are needed. In general, a S/N of 3 represents the
limit of detection (LOD) [58] but in most cases, the quantification of
such small peaks might result in lower precision. For these cases
Fig. 3. Typical set of NMR experiments for the automatic profiling of cell extracts and culture media samples. A: spectral region from the 1D 1H NOESY experiment of cell extract.
The intensities and areas of peaks are dependent on the concentrations of the metabolites, and thus provide a quantitative fingerprint of the complex mixture. B: the same spectral
region from the 2D Jres spectrum, retaining the protons chemical shifts (horizontal axis) and displaying their coupling constants (in Hz) on the vertical axis. Singlets (no spin e spin
coupling) are displayed as a single peak at the center frequency (0 Hz), while multiplets (doublets, triplets, quartets, etc.) are shown as two peaks symmetrically positioned around
0 Hz, with the distances between them being equal to their coupling constants in Hz. The dispersion of couplings fine structure in a second dimension, allows for the resolution of
complex multiplets, which are otherwise overlapped in the 1D spectrum. This information (chemical shifts and couplings) is extremely valuable for the accurate fitting of pure
compounds with the peaks in the complex mixture.
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S/N, for which an acceptable precision is achieved [51]. In a pilot
study with cell culture media, we have used tryptophan quantifi-
cation as a representative measure to decide upon the precision
and the experimental time needed to achieve it. Tryptophan is
commonly present in both culture media and intracellularly,
however it is usually one of the less abundantmetabolites and thus,
it is a good example to estimate the experimental time.We used the
BATMAN peak fitting software (see section 4.2.1 for BATMAN
software details) to fit the 2 doublets at d 7.55 and 7.74 ppm. We
obtained a coefficient of variation (CV) of 10.61% at a S/N ¼ 12.55,
while for a S/N ¼ 43.62, the CV was slightly reduced to 9.72%. A CV
in this range (~10%) is frequently acceptable and therefore, we
concluded that for this study a S/N of ~15 was sufficient to achieve
our limit of quantitation.We should note at this point however, that
often, the precision is also dependent on the complexity of the
resonance and the method used for the quantification. We discuss
further about this topic and the accuracy of quantification in section
4.2. In section 5, we also comment on the results of our quantifi-
cation of cell extracts as well as, cells-free DMEM/F12 medium,
with and without FBS.
As a general indication about NMR measurement times, using
3 mm tubes and 165 mL of sample, on a 600 MHz NMR spec-
trometer equipped with a cryoprobe, 25e40 min are needed to
acquire both profiling experiments for samples in the range of
1  107 cells. However, with less cells (e.g. 1e5  106), mea-
surement times can reach up to an hour (e.g. 512 scans for 1D
NOESY) in order to increase metabolic coverage within the LOQ
and improve the precision of the quantification in the low mM
range.3.3. Data processing and quality assessment
Typically, NMR data are processed automatically after data
acquisition. This includes phase and baseline correction, refer-
encing to the chemical shift of the TSP (or DSS) methyl groups at
d 0.0 ppm and line broadening (LB 0.1e1.0 Hz) to increase S/N.
However, it is common practice to perform manual corrections in
addition to the automated ones, especially for the correct phasing
of the spectra [51]. On the other hand, the choice of the appropriate
line broadening is also dependent on the method to be used for
quantification. In general, a small line broadening of 0.1e0.3 Hz,
will induce a small increase in S/N without compromising resolu-
tion and it is recommended for the analysis of complex mixtures
with many overlapping resonances. If Chenomx is used for quan-
tification, often a line broadening of 0.5e1 Hz, provides better
fitting of the reference compounds to the metabolites in the
spectra, even though the resolution is reduced. For example, the
company mentions that the best overall fitting is achieved for DSS
(or TSP) half-height linewidths from 1 to 1.5 Hz. Overall the choice
of the LB factor is case dependent, but since this is a processing
parameter, it can be changed easily on the same raw dataset as
many times as needed, without destroying the recorded data
(stored in the form of free induction decay; FID).
The quality of the processed spectra can be quickly evaluated by
calculating the linewidths of the TSP (or DSS) singlet. We also
routinely use Alanine's methyl protons doublet (at d 1.48 ppm),
using a half height linewidth value of 1.2 Hz as a cut-off above
which the sample is examined further whether it should be re-
measured or discarded from subsequent analysis. Moreover, mul-
tiple spectra overlay helps to identify inconsistencies in the data.
NMR spectra from samples that were properly prepared and
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baseline offsets after the corrections and the residual water peak
should not affect the spectral baseline outside of 4.65e5.1 ppm for
cryoprobes or 4.7 to 4.9 for the room-temperature operating in-
verse probes. Furthermore, there should not be any peak drifting or
only minimal for the protons with pKa values close to the pH of the
sample (e.g. histidine's imidazole proton and in some cases those
from histamine and citrate). Finally, the integrals and the peak
shapes of the internal standard's singlet should be identical across
all spectra so that it can be used for quantification of the other
resonances. Large deviations of the TSP peak area and shape might
be due to insufficient protein removal during sample preparation,
as TSP (and DSS) is known to bind non-specifically to several
macromolecules present in plasma and serum. In that case, only
relative quantitation is possible, unless a second measurement is
carried out or a correction based on other standards is available
(Fig. 4).
4. NMR data analysis
In metabolomics studies, it is common to initially analyse the
NMR data in a non-targeted manner [59e62]. Hence, the full
spectral area is taken into account with no prior knowledge of the
compounds ID and multivariate models are constructed that seek
how the NMR fingerprints of each sample and between groups of
samples, are related to each other [61]. While this approach pro-
vides a first global view of the underlying trends and differentiation
patterns in the data, it is often not valuable for the analysis of
mammalian cell lines [63]. It is rather the metabolites ID and their
relative fluctuation in the data which are ultimately needed in or-
der to understand metabolic processes and thereby address the
study's specific questions and understand the underlying biology.
In turn we will here focus on the targeted identification andFig. 4. Overlay of spectral regions from nine 1H NMR automatically processed spectra of cu
medium collection. While further manual processing is possible, even after the automatic pr
the metabolites). This is a result of the standard sampling procedure and the optimized in
Histidine, while there is no baseline offset around the residual water resonance (baseline at
(TSP in this case) in all spectra, allows the direct use of it for quantitation of the extracelluquantification of metabolites in (mammalian) cell lines.
4.1. Metabolite identification
Spectra annotation in NMR spectral data of cell extracts and
culture media can be, to some extent, a straightforward and rela-
tively easy task for an experienced user. This is because all
commonly detectable metabolites in this kind of samples (e.g.
amino acids, carbohydrates, amines, carboxylic acids, etc.) have a
unique peak pattern (fingerprint), which is well-defined and
repeated across all spectra for a specific pH, solvent and tempera-
ture [59]. Moreover, it is common to compare the datawith spectral
databases using search tools. The most commonly used and freely
available metabolite databases are the Human Metabolome Data-
base (HMDB; http://hmdb.ca) [47], the Biological Magnetic Reso-
nance Data Bank (BMRB; http://www.bmrb.wisc.edu) [64] and the
Birmingham Metabolite Library (BML; http://www.bml-nmr.org/)
[65]. Other well-known commercial databases are the Bbiorefcode
(Bruker Biospin Ltd.) and Chenomx library (Chenomx Inc.).
While searching in databases is very helpful, there will usually
be a considerable number of resonances with ambiguous annota-
tions that cannot be identified solely on database related infor-
mation. Such assignments need further verification using 2D NMR
data as well as the information from nuclei other than 1H, e.g. 13C or
15N [63,66]. For example, overlapping of methyl protons peaks of
several metabolites at d 0.85e1.15 ppm, is a frequent case where
assignment from only the 1D spectra is not sufficient. In such cases,
analysis of the spin e spin correlations using 1He1H COSY and
TOCSYexperiments, usually provides the necessary information for
deducing the correct ID of the compound(s). In Fig. 5Awe show two
characteristic examples where the TOCSY spectrum is used for the
assignment of 3-methyl-2-oxoavalerate and 2-oxoisocaproate. On
the other hand, the proton - proton correlation experiments are notlture medium from BHP2-7 cells. The samples shown here, represent 3 time points of
ocessing only, the biological variation is evident (i.e. 3 groups of triplicates for some of
strumental parameters. Specifically, peak drifting is minimal and occurred mainly for
0). Furthermore, the reproducible linewidth and integral of the internal standard peak
lar metabolites.
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methylamine-N-oxide (TMAO) both resonate closely at d 3.26 ppm.
However, the carbon chemical shifts of the methyl groups are at
d 55.8 ppm for betaine and at d 62.2 ppm for TMAO and this in-
formation is easily obtained by the 1He13C 2D Heteronuclear Single
Quantum Correlation (HSQC) experiment (Fig. 5B).
These examples demonstrate the need to acquire 2D NMR ex-
periments in addition to the 1D NOESY and 2D Jres. However, in
practice this cannot be done for all samples as 2D NMR experiments
(with the exception of the ultra-fast Jres) require long experimental
times. Instead, a small selection of samples can be made, e.g. one
sample from each group of cells, for which a 2D NMR spectrumwill
be recorded. Alternatively, it is even better practice to create pool
samples (e.g. from the leftovers of each sample during sample
preparation) which will provide a closer representation of the
metabolites in all samples rather than those present in a subset. A
typical set of 2D NMR experiments include the 1He1H COSY and
TOCSY, a Jres spectrum as well as a 1He13C HSQC while often, an
HMBC (Heteronuclear Multiple Bond Correlation) can also be useful
[54]. The HSQC experiment provides information on the single
bond connectivity between protons and heteroatoms, most
commonly 13C, but 15N or 31P are also used. It is a very versatile
experiment formetabolites identification in complexmixtures for 3
reasons. First, it simultaneously provides the chemical shifts of the
protons and their attached heteroatoms (e.g. carbons). Second, the
much broader dispersion of carbon chemical shifts (up
to ~ 220 ppm), assists greatly the analysis of the otherwise heavily
overlapped resonances in the proton spectrum. And third, a very
common variant of HSQC can provide carbon multiplicity infor-
mation as well. In this multiplicity edited-HSQC, the 1He13C cross
peaks are phase-sensitive, so that the methyl (CH3) and methine
(CH) moieties are of opposite phase than the methylene (CH2) ones
[67]. The HMBC experiment, shows correlations through coupling
of protons with heteroatoms that are further away, up to 3 or 4
bonds. These long range couplings are very different in magnitude
from the one-bond ones (for 1He13C, 1JCH ¼ 100e300 Hz,
24JCH  10 Hz) and since the one-bond correlations are depicted in
the HSQC, it is common to simplify the HMBC spectra by excluding
the one-bond cross peaks using a low-pass filter [54]. Although less
used, the HMBC can provide valuable, complementary information
for metabolites structure and identity. An example of the param-
eters used in some of these experiments is provided in the
supplementary material S2.
In most cases, the combined use of database search and 2D NMR
helps to annotate most, if not all detectable peaks in the spectra.
However, in some cases even more work needs to be done. Char-
acteristic examples are the uridine diphosphate (UDP) conjugates
often found in NMR spectra of cellular extracts, e.g. UDP-N-ace-
tylglucosamine (UDP-Gluc-NAc), UDP-glucose (UDP-Glc) and UDP-
glucuronic acid, among others. These molecules are typically pre-
sent at very low concentrations and most of their peaks are heavily
overlapped with other more intense signals (e.g. UDP-glucose with
the more abundant D-Glucose) and thus are not easily resolved for
their identification, even in 2D NMR. However, their peaks at
d 5.50e5.65, d 5.90e6.00 and d 7.85e7.95 ppm, have sufficient S/N
and can be used for quantitation. The only prerequisite for this is
the knowledge of the exact chemical shifts for each compound, as
they resonate closely to each other (Fig. 6). Unfortunately, due to
their usually low concentration in the sample, 2D NMR experi-
ments are often not sensitive enough to display these protons and
their corresponding carbons. In these or similar cases of ambiguity,
spiking of reference compounds is recommended as the best option
for unambiguous identification and quantitation. The reference
compounds are added in concentrations of about 10e100 mM,
depending on the compound, subsequently the 1D NOESY and 2DJres experiments are repeated. In Fig. 6 we show one example
where spiking of pure UDP-N-acetyl-glucosamine was performed.
In section 5 we also provide a table with all metabolites found in
the BHP2-7 cell line using all the above-mentioned methods.
Obviously, this list is cell specific and can only be seen as a
framework representing what should be anticipated from NMR
studies of cellular extracts.
4.2. Quantification of metabolites in NMR spectra
The quantification of NMR spectral resonances relies on the
fundamental property that the areas of these resonances are
directly proportional to the number of protons they consist of. Once
the latter is known after spectra annotation, the peak areas have to
be extracted in order to generate quantitative data of the metabo-
lites. Metabolite relative concentrations can simply be obtained by
comparing peak areas of analyte and internal or external standard
[51,59]. Since no form of chromatographic separation is usually
applied upfront NMR-based profiling approaches, a huge dynamic
range of metabolite concentrations can be observed in a single
proton spectrum, ranging from low mM to high mM. However, NMR
benefits from its large linear dynamic range and signal response (up
to 6 orders of magnitude) and this, together with the use of modern
digitizers, allows for quantification without the need of calibration
lines (in case of calculation of ratios) such as in the case of MS-
based methods.
Several approaches have been developed, to generate a “refer-
ence” for the absolute quantitation in the field of biomolecular
NMR [51]. Among them, the addition of an internal standard (TSP or
DSS) is commonly applied for the targeted profiling of mammalian
cells. This method also benefits from the fact that the samples are
deproteinized before the addition of the buffer and the internal
standard and therefore, no variation is expected due to binding
effects. Using this approach, the relative concentration of a
metabolite is calculated in relation to the known concentration of
the internal standard using the areas of the corresponding reso-








where M and S, are the concentrations of the metabolite and the
internal standard (S is known), IM and IS are the integrals of their
resonances and NM and NS are the number of protons contributing
to these resonances, respectively. However, since both DSS and TSP
methyl protons have long T1 relaxation times and short repetition
times (t) are used (see section 3.2) t becomes < 5  T1 and there-
fore, the TSP (or DSS) resonances are attenuated. Consequently,
their integrals do not reflect their real concentration and the
quantities of metabolites will also be affected by this error. As
mentioned earlier, this is not a problem if relative concentrations
are sufficient for the purposes of the study. However, if absolute
concentrations are required then a correction for the T1 times
should be applied with regard to the repetition time used [51]. This












where, [Mreal] and [Mcalc] are the corrected and quantified con-
centrations for repetition time t, and T1S and T1M are the T1 relaxation
times of the resonances of the internal standard S and from
metabolite M, respectively. The T1 times can be easily calculated
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struments). The NMR dedicated software used for each system (e.g.
Topspin for Bruker) usually provides automatic routines to extract
the relaxation times from the inverse-recovery experiments
together with detailed instructions how to perform them. Using the
same buffer as we propose in this tutorial and a temperature of
300 K in our 600 MHz instrument, we have calculated a T1 of 3.22 s
for TSP and 3.19 s for DSS.
During the above calculations, it is assumed that the concen-
tration of the internal standard is accurately known. Unless a
commercial certified solution is used, the accurate concentration
has to be verified in house. After some recent developments, this is
possible using an artificial reference standard. We provide some
details on this in the next paragraphs. However, the conventional
way followed so far is to mix an aliquot from the solution that
contains the internal standard (in the present tutorial, this is the
buffer in D2O) and an aliquot from a solution with a reference
compound. The latter, should ideally having a singlet resonance
away from the TSP (or DSS), e.g. formate (d 8.45 ppm), or acetate (d
1.91 ppm). Then a single pulse qNMR experiment is performed
using a long repetition time (t ~ 30e40 s) to ensure that t
becomes > 5  T1 for both the TSP (or DSS) and the reference
compound resonance. For example, if sodium acetate is used to
calibrate the TSP concentration in a 600 MHz NMR spectrometer
operating at 300 K, then the repetition time should be at least
23.75 s (i.e. 5  4.75) to account for the longer T1 of the acetate
methyl protons (T1 of acetate CH3 is 4.75 s and T1 of TSP (CH3)3 is
3.22 s). The absolute concentration of TSP (or DSS) is then calcu-
lated by integration of both resonances and use of the integrals in
equation (1). Fortunately, this process has to be performed only
once the standard solution is made and the calculated concentra-
tion can then be used as long as the same stock solution (e.g. the
buffer) is used for any study at the same temperature and the same
instrument. In supplementary information (S3) we provide the
experimental parameters suggested by Chenomx. Even if a
different reference compound is chosen (Chenomx uses 50 mM
sodium acetate), the provided experiment can be performed by the
readers on their own set up.
An alternative approach was recently proposed [10] for the
absolute quantitation of cell cultures that does not require any
reference material. The method uses the PULCON quantitative NMR
(pulse length-based concentration determination), which is based
on the principle that the absolute signal intensity is inversely
proportional to the length of the 90 pulse used for the nuclei
excitation in the active volume of the NMR tube [68]. This approach
has the advantage that it requires only a single reference spectrum
(calibrated once every few months) which can be used with all
samples, throughout several studies. However, a serious disad-
vantage is that themethodworks for well-resolved peaks but not in
the case of overlapped ones, which is typically the case in complex
mixtures. Due to this, the authors have used PULCON only for the
quantification of a small set of metabolites from culture media.
However, the PULCON method can still provide a good alternative,
for example, for the verification of the real concentrations of the
internal standard in each sample of a study.
As we mentioned above, some efforts have been made to avoid
using any internal standard and achieve quantification with
external calibration. To this end, the Electronic Reference To access
In-vivo Concentration (ERETIC) was developed [69]. ERETIC is an
electronically generated signal though a second channel of the
probe (e.g. 13C), which is added as a pseudo-FID during the acqui-
sition of the proton experiment. It presents all the characteristics of
a regular NMR signal and only needs to be calibrated against a
reference solution before it can be used for the quantification of
metabolites [51]. The disadvantages of the ERETIC method are, thatsome hardware rearrangements are needed and also the signal is
affected when the quality factor (Q-factor) of the probe is changed
due to different sample properties (e.g. dielectric properties).
Although, the latter has been dealt with a method that applies a
correction to the ERETIC signal based on the pulse length of each
sample [70], some other recent developments, namely the ERETIC2
(Bruker Biospin, Topspin 3.0) and QUANTification by Artificial
Signal (QUANTAS) [71] have opened new possibilities for quanti-
tative NMR. Both methods are generating a digital reference signal
which can be positioned anywhere in the spectrum, e.g. in a clear
spectral area or close to TSP and DSS and they don't require any
additional hardware. Like ERETIC, one first has to calibrate the
digital reference by acquiring an qNMR experiment with a verified
reference solution and then this digital reference can be used for
accurate quantification. We have not yet used any of these ap-
proaches in our studies withmammalian cells and therefore cannot
provide more experimental details in this tutorial. However, we do
anticipate that both QUANTAS and ERETIC2 can greatly facilitate
the NMR-based profiling, at least, by removing any inconsistencies
related with the internal standard concentration, as for example,
when one needs to use very small volumes of sample, suitable for
microprobes.
4.2.1. Deconvolution of NMR peaks
Simple resonance integration works well for isolated peaks and
when using the appropriate corrections, absolute concentrations
can be extracted. However, the requirement for well dispersed
peaks is hardly met in complex mixtures, such as those from cell
extracts. Quantitation of peak areas from these NMR spectra, re-
quires more sophisticated methods than integration [51]. In such
cases, line-fitting approaches (also termed as deconvolution) are
preferred. Deconvolution is achieved by fitting a target peak of the
compound in the complex mixture, with the one of the pure
compound in reference spectra [72]. Among the available algo-
rithms and software packages for targeted profiling, in our opinion
the commercially available Chenomx NMR Suite can be considered
as the gold standard. It comes with an internal database of math-
ematically modelled metabolites (341 in the current version, 8.2),
consisting of the chemical shift and the J-coupling information and
allows for the interactive fitting of peaks in a semi-automated
manner [73]. The interactive fitting mode allows for fine adjust-
ments of peak shapes by the user, albeit the more complex the
mixture and the higher the number of the metabolites to be
quantified, the more time consuming the process. In addition, the
higher user interaction is a potential source of errors, hence a
standardized processing practice should be followed [74].
The performance of quantification by Chenomx NMR suite, is
dependent on several factors. First and most important, the library
of reference compounds is built using a 1D NOESY experiment
(called METNOESY; parameters are provided in supplementary
material, S3) and the best fitting results can be achieved when
the NMR data acquisition for each study, has been done with the
exact same experimental parameters. Variations in the pulse
sequence and/or the repetition time, will result in a less accurate
fitting. It is important to note at this point that, if the recorded NMR
data follow the protocol suggested by Chenomx then absolute
concentrations of metabolites can be extracted without any T1
corrections (we encourage the reader to visit http://www.
chenomx.com; Application note 14: “Investigating the criteria for
accurate quantitative results with Chenomx NMR Suite”). However,
if this is not the case, the quantification results in relative con-
centrations. In order to assess this, further, we have compared the
results obtained by our “metabolic profiling” NOESY experiment
(see sections 3.1 and 5.1.3) and the METNOESY in cell-free culture
medium samples and we provide the results in section 5.
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Fig. 6. Spiking of pure compounds (~20e100 mM) into a mixture helps to identify the existence of metabolites and their exact position in the spectrum. A: The spiking of UDP-N-
acetylglucosamine (UDP-Gluc-NAc) is shown (indicated with red dotted lines), after which, the identification and quantitation of this compound was achieved by fitting the peaks
shown in the two spectral regions (left and right); B: The same regions from the 1D NOESY spectrum of the mixture without the addition of UDP-Gluc-NAc. On the left side, the
proton of UDP-Gluc-NAc at d 5.50 ppm is overlapped with the one from Galactose-1-phosphate (Gal-1-P), while the two protons from the uridine moiety at d 5.95 ppm are
overlapped with those from UDP-glucose. Moreover, it is very difficult to assign the exact chemical shift of the three protons from the acetyl group for UDP-Gluc-NAc, shown on the
right side, as these are overlapped with other multiplets from glutamine and glutamate as well as the singlet frommethionine's methyl protons. (For interpretation of the references
to colour in this figure legend, the reader is referred to the web version of this article.)
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is related to the properties of some protons, called labile, e.g. those
attached to a nitrogen atom. These protons are often in exchange
with the solvent which not only make them undetectable but also
influences the resonances of the other vicinal protons causing a
slight attenuation of their peaks. The consequence is that the
attenuated resonances do not match exactly to the areas calculated
for the other protons in the same compound. Typical examples of
this are the a protons of amino acids which are vicinal to the amine.
When Chenomx is used for deconvolution, one should consider
other protons, preferably more isolated resonances, as better tar-
gets to achieve more accurate results. For example, in Valine
profiling, the two doublets of the methyl protons at d 0.99 and
1.04 ppm as well as the multiplet at 2.26 should be prioritized over
the a-H at d 3.67 ppm, which is usually not fitted well. In a recent
study the performance of the software was evaluated using a
synthetic mixture of 28 metabolites, commonly found in
mammalian cell cultures [75]. The authors pointed out two major
sources of bias: the incorrect interpretation of singlets and the
quantification of resonances from protons in close proximity to
labile protons. In addition, quantification of three metabolites,
glutamate, tryptophan and arabinose was found less accurate at
low concentrations.
As already mentioned in section 3.1, the presaturation of theFig. 5. High resolution 600 MHz 2D NMR experiments of a cellular extract. A: The 1He1H TO
cross peaks, symmetrically positioned around the diagonal. This experiment provides the s
resonances, especially for the cases of protons being in a similar chemical environment. Two
of 3-methyl-2-oxovalerate where the two methyl groups are annotated by their correlations
from the two methyl groups of 2-oxoisocaprotate (red color) are overlapped with the methy
peak with the methylene protons at d 2.61 ppm. B: The 2D 1He13C HSQC experiment of the s
shift scale being on the vertical axis. It is also common to use an edited version of the pulse
example, CH3 and CH are having a positive phase (blue peaks) while CH2 have a negative p
occurs (i.e. singlets in the 1D spectrum and no TOCSY cross peak). An example is shown
overlapped and misinterpreted with the ones from TMAO but they can be well resolved in
references to colour in this figure legend, the reader is referred to the web version of thiswater resonance also causes a partial peak saturation in the protons
resonating close by. This is another type of error that is induced in
the quantification of these resonances, and should be considered,
especially with Chenomx profiling [76]. For example, it should be
expected that the fitting of the anomeric protons from carbohy-
drates, commonly resonating close to the water resonance, will not
match the fitting of other resonances of the molecules. Another
typical example comes from lactate profiling for which the CH
quartet at d 4.11 ppm is usually affected by the presaturation. In this
case, the doublet of the methyl protons at d 1.33 ppm should be
given preference for quantification.
We have extensively used Chenomx for both intracellular and
extracellular metabolite profiling. Since an increasing number of
researchers are using or intent to use this software, we consider it
useful to provide the readers with some practical guidelines and
recommendations, as derived from our experience with real life
analysis of cells samples. As with most NMR quantification rou-
tines, one important asset of a successful quantification procedure
is the pre-processing of the NMR spectra. Chenomx offers the
possibility to process the raw data from scratch, i.e. phase and
baseline correction, referencing to the internal standard and
correction for the pH of the sample. However, some of these
functions are easier done on the NMR dedicated software (e.g.
Topspin). We should also note that for TSP and for samples with pHCSY spectrum displays the spin - spin correlation through bonds for each compound as
pin system of each compound and hence allows to resolve and annotate overlapping
examples are shown in the zoomed spectral window on the right: First, the assignment
with the other protons of the molecule (CH2 and CH; green color); Second: the protons
l group of Isoleucine at d 0.93 ppm in the 1D spectrum but can be assigned by the cross
ame cellular extract as above. The HSQC displays C-H correlations with carbon chemical
sequence so that additional information on carbon multiplicity can be shown. In this
hase (red peaks). HSQC is extremely useful in cases where no spin e spin correlation
in the zoomed area with the annotation of betaine's methyl protons. These are often
the 2D HSQC base on the different carbon chemical shift. (For interpretation of the
article.)
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d 0.0159 ppm, therefore, for convenience it is advisable to also
perform this in the raw dataset. With regard to the functions pro-
vided by Chenomx, we have found the fine adjustment of the
baseline, using the spline tool very useful. Moreover, since, the
profiling depends on the internal standard, it is of utmost impor-
tance to properly calibrate the TSP (or DSS) singlet. This includes
the careful baseline and phase correction of the area around 0 ppm,
and the accurate calibration of the linewidth. Commonly, peak half-
height linewidths of 1.0e1.5 Hz result in the best overall fitting to
the modelled compounds of the Chenomx library. One good
approach is to fit a small, representative set of metabolites until the
optimal process settings are found. We also suggest the evaluation
of other peaks linewidths (using different software), like the one
from alanine's methyl-doublet at d 1.48 or D-glucose a-anomeric
proton at d 5.23 ppm as a rough estimation of the best linewidth
setting for the fitting of the reference spectra. On the other hand, if
the linewidths are significantly broader than 1.5 Hz, a shimming
correction (reference deconvolution) should be applied. However,
for better accuracy and precision, samples with poor resolution,
should preferably be discarded from further analysis. Using these
quality criteria, we have quantified tryptophan in 8 extracts of a cell
line (See, Section 5. Case study and Table 1) with a mean concen-
tration of 7.6 mM (0.38 mM/106 cells) and a CV of 16.56%. In cells-free
culture medium with a given concentration of 44 mM (from the
supplier), we obtained 40 mMwith a CV of 9.93% in DMEM/F12 with
10% FBS, and 47 mM with a CV of 1.29% in DMEM/F12 without FBS.
Tryptophan has been reported [75] to result in inaccurate quanti-
fication, but in our case the results were acceptable.
Although Chenomx profiler is capable of fitting all known me-
tabolites in the spectra automatically, our experience is that this
will result in errors, especially for heavily overlapped peaks. A
manual review of the fitting results is therefore necessary. In
addition, the order of fitting seems to be important. As an example,
starting the profiling with D-glucose resonances, will probably lead
to errors as glucose is generally present at much higher levels and
its resonances will mask other overlapping peaks originating from
metabolites with very low concentrations. The same is true for
singlets, which often resonate on top of other multiplets of lower
intensity. A typical example of this is the singlet of succinate which
overlaps with the multiplet from pyroglutamate. One should start
the profiling with low abundant multiplets before fitting the sin-
glets. An extremely useful feature of Chenomx is the subtraction
line. This is the spectral line left after fitting of a resonance. Ideally it
should be zero, but in some cases, other unknown peaks are
overlapping with the targeted ones and thus, the spectral line is not
fully fitted. Finally, we have found it very useful to initially analyse,
a mixture of known composition, in order for the analyst to tune
the fitting process. We typically use blank culture medium from the
study, ideally without FBS addition. In this manner one can
compare the results to the manufacturer's specifications. However,
please note that for the best accuracy, NMR data should be collected
as suggested by Chenomx as discussed previously. In our experi-
ence though, even with a different experimental set up, as the one
we propose in this tutorial, the quantification results are close to
the theoretical ones. We are addressing this point in more detail in
section 5.2.2. Overall, despite the challenges mentioned above
when it comes to quantification of metabolites in complex mix-
tures, the great advantage of Chenomx is that it can provide the
absolute or relative levels (at least a close estimation) of many
metabolites with heavily overlapped resonances. This is mainly
achieved because the software fits the full spin system of each
compound rather than a single resonance and with some experi-
ence and knowledge of the pitfalls we mentioned above, almost a
full spectrum coverage can be achieved. This increases themetabolic coverage significantly comparing to other available op-
tions, and makes NMR an attractive alternative in studies of
mammalian cells metabolism.
Besides Chenomx, MestreNova (MNova) software (MestreLab
Research SL) is also gaining popularity in the analysis of complex
mixtures. Unfortunately, we do not have any experience with
MNova, and thus, we cannot provide any recommendations, but the
interested reader can look at the documentation provided online.
Two other methods, BATMAN [77,78] and BQuant [79], have the
advantage that they are freely available and can be used through
the R statistical environment (http://www.R-project.org/). Both
approaches are based on a Bayesian model to develop the most
probable fitting of a peak based on specific input data. BQuant re-
quires prior alignment and peak picking of the spectra. On the
contrary, the BATMAN (Bayesian automatedmetabolite analyser for
NMR) R package, fits NMR peaks on the basis of user-defined
templates of chemical shifts, J-couplings, multiplicity of peaks
and relative peak intensities (i.e. number of protons). An extensive
template file is freely available to download from the HMDB data-
base with approximately ~2500 peak patterns, corresponding to
about 600metabolites. The template is fully customizable, allowing
the users to change the parameters based on their own experi-
mental values. Based on the template info, the software renders an
ideal peak and subsequently tries to fit it to the experimental signal
by minimizing a mathematical function. In contrast to Chenomx
which fits the full spin system of a compound, BATMAN allows the
user to decide upon which resonance to fit. Apparently, a priority
should be given to the most isolated ones before trying to fit the
more complex peaks. The output file is the area calculated for each
proton, i.e. it can be directly used for comparison of compounds'
levels across multiple spectra with no further correction. However,
if an internal standard is used then the output can be converted to
relative concentration or to absolute concentration after T1 cor-
rections, as we mentioned in section 4.2.
While BQuant has to our knowledge not yet been applied to
cellular extracts and culture media, BATMAN has been successfully
used for the quantification of 25 extracellular metabolites from 86
single-gene transposon insertion mutant strains of the pathogen
Pseudomonas aeruginosa [80]. The samples of this study exhibited
large pH variations and one extra feature of BATMAN was partic-
ularly useful in dealing with severe shifting of peaks across the
spectra: the ability to sort spectra based on the shifting of a target
peak and extract the chemical shift information in order to use it for
the template file. This is achieved by the splineFitBATMAN inter-
active tool [81], which runs in Matlab (The Mathworks Inc.).
Furthermore, the authors found good agreement of the quantita-
tion results from BATMAN in comparison to a sample which was
profiled with Chenomx. The limitations of BATMAN are the
required computational power, which slows down the process in
case of large spectra numbers and the poorer fitting in case of more
complex multiplets or severely overlapped peaks, when compared
to Chenomx. This results in a reduced number of quantifiable
compounds in a mixture but nevertheless, in our opinion it is still
an excellent choice for quantification of NMR data, if Chenomx is
not an option. For the purposes of this tutorial, in section 5.2.2 we
provide the results of a comparative analysis for a subset of me-
tabolites using BATMAN and Chenomx. For further details about
how to construct the BATMAN template files, load the spectra and
use the splineFitBATMAN tool in Matlab, the interested reader is
encouraged to look at the online documentation of the package at
http://batman.r-forge.r-project.org, as well as the provided refer-
ence [78].
4.2.2. Correction and evaluation of the quantitative data
As cell cultures can typically consist of different cell numbers
Table 1
Intracellular and extracellular metabolites identified by NMR based targeted profiling. The listed chemical shifts for each compound, were used for quantification via fitting
with its reference spectrum from the library of ChenomX NMR suite. The mean concentration and CV (%) is also shown for the intracellular metabolites from a set of 8 cell
extracts from the BHP2-7 cell line. For a limited number of metabolites, the quantification was repeated with BATMAN and the results are shown in parentheses.
Metabolite d 1H (ppm)a Conc.d,e CV (%) Metabolite d 1H (ppm)a Conc.d,e CV (%)
1-Methyl-
nicotinamide
4.47, 8.17, 8.89, 8.96, 9.27 0.62 4.37 Malate 2.34, 2.65, 4.29 2.20 12.49
a-ketoglutarate 2.42, 2.99 0.78 8.26 Methionine 2.11, 2.12, 2.18, 2.63, 3.84 0.96 23.15
2-Oxo-isocaproate 0.92, 2.60 0.34 34.14 Methyl-malonatef 1.23, 3.16
3-methyl-2-
oxovalerateb
0.88, 1.08, 1.44, 1.68, 2.91 Methyl-succinatef 1.07, 2.11, 2.51, 2.61




N,N-Dimethyl-glycinec 2.90 0.11 3.96
Acetatec 1.90 2.32 6.81 N-Acetyl-aspartate 2.00, 2.48, 2.67, 4.38 1.28 7.54




N-Acetyl-glutamine 1.91, 2.02, 2.31, 4.15






Asparagine 2.84, 2.94, 3.98 0.35 45.06 Nicotinate adenine
dinucleotide
4.40, 4.51, 6.03, 8.04, 8.14, 8.42, 8.73, 8.99,
9.12




Betaine 3.25, 3.89 0.34 16.65 Ornithine 1.78, 1.92, 3.04, 3.77 0.75 40.66
Choline 3.19, 3.50, 4.05 0.59 29.82 Pantothenate 0.88, 0.92, 2.40, 3.97 0.42 13.45
Citrate 2.53, 2.64 0.98 9.54 Phenylalanine 3.12, 3.27, 3.98, 7.32, 7.36, 7.41 1.73 22.66
Creatine 3.02, 3.91 1.40 5.94 Proline 1.98, 2.05, 2.34, 3.33, 3.40, 4.12 6.29 6.84
Phospho-creatine 3.03, 3.93 2.54 5.53 Pyroglutamatec 2.02, 2.39, 2.49, 4.16 5.45 32.61
Formatec 8.44 0.74 23.01 Pyruvateg 2.35 0.27 31.17









GTP 5.93, 8.13 0.14 9.88 Taurine 3.25, 3.41 10.76 4.41
Galactitolf 3.68, 3.97 Threonine 1.31, 3.57, 4.24 4.97 18.54
Galactosef 3.48, 3.63, 3.69, 3.72, 3.79, 3.84, 3.92, 3.98,
4.07, 4.58, 5.26
Tryptophan 4.05, 7.19, 7.27, 7.31, 7.53, 7.72 0.38 16.56
Glucose 3.23, 3.39, 3.45, 3.50, 3.71, 3.81, 3.88, 4.63,
5.22
61.86 35.21 Tyrosine 3.05, 3.18, 3.92, 6.89, 7.18 2.21 23.38
Glutamate 2.04, 2.11, 2.34, 3.74 36.69 3.17 UDP-Gluc-NAc 2.06, 3.54, 4.27, 4.36, 5.50, 5.96, 7.93 0.63 10.41
Glutamine 2.13, 2.44, 3.76 12.39 18.60 UDP-glucuronate 4.38, 5.62, 5.97, 7.93
Glutathione
(reduced)




UDP-Glucosef 4.19, 4.23, 4.27, 4.36, 5.59, 5.97, 7.94
Glycine 3.55 6.23 8.39 UDP-Galactosef 4.27, 4.35, 5.63, 5.97, 7.95
Histidine 3.12, 3.22, 3.98, 7.08, 7.87 0.94 22.55 UMPf 4.34, 4.41, 5.98, 8.09
Hypotaurine 2.63, 3.34 4.21 6.33 Valine 0.98, 1.03, 2.26, 3.59 3.87 23.60














3.22, 3.60, 3.64, 4.31 0.89 6.21
Leucine 0.94, 0.95, 1.70, 3.73 3.10 24.75 b-Alanine 2.54, 3.16 3.00 5.81
Lysine 1.46, 1.72, 1.89, 3.01, 3.74 2.52 36.88 CoA 0.72, 0.84, 2.60 0.25 23.53
Cystineb 3.18, 3.38, 4.08 2-hydroxy-isobutyratec 1.35
Hypoxanthineb 8.18, 8.20 3-hydroxy butyratec 1.19, 2.30, 2.40, 4.14
Pyridoxineb 2.45, 7.64 Niacinamideb 7.58, 8.24, 8.70, 8.93
trans-4-hydroxy-L-
prolinec
2.14, 2.42, 3.35, 3.47, 4.33 Galactose-1-phosphatef 3.72, 3.76, 3.90, 3.99, 5.48
a All chemical shifts are based on the TSP calibrated at d 0.0159 ppm.
b Present only in the culture medium.
c Not listed in culture medium formulation but identified by NMR in cells-free medium samples.
d Concentration (Conc.) is expressed as mM/106 cells after, in total ~ 24.5 millions cells were extracted per sample; CV (%): coefficient of variation; calculated from a set of
8 cell extracts used for this tutorial as (std/mean)*100.
e Quantification was performed with Chenomx NMR Suite 8.1. In parentheses are the results of quantification with BATMAN for a subset of the metabolites.
f These metabolites were identified in BHP2-7 cell lines in a separate experiment after specific treatment (ongoing study).
g Pyruvate and oxaloacetate have the same chemical shift and cannot be quantified separately in proton NMR.
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is needed. Such is necessary in order to make the extracted con-
centrations comparable between different experiments, cell lines
and culture media. Although this topic is not an integral part of the
here described quantitative NMR method, it is important for the
user to consider corrections taking different cell numbers, biomass
or even cellular volume into account. The latter is particularly
important if the intracellular metabolomes from different cell types
are to be compared. In our experience, when comparing cells from a
single experiment or rather similar cell types, correction for totalprotein has been proven to be the most straight-forward approach.
We usually re-dissolve protein pellets obtained after the precipi-
tation step in 10% sodium dodecyl sulphate for subsequent BCA
based protein quantification. Also, corrections based on cell
numbers are frequently used and have proven their feasibility.
An additional point that requires evaluation is the starting
composition of the culture medium. Although the manufactures
often provide a detailed list of nutrients in the medium, an evalu-
ation of the actual composition used in each study is strongly
recommended. Especially for media with FBS, it is often the case
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starting conditions. Such differences can vary between batches of
culture medium or FBS and may prove significant when absolute
concentrations are used throughout several experiments, particu-
larly when studying metabolite uptake and release. Hence, close
monitoring of culture media and batch control are mandatory. In
our laboratory, we routinely measure cell free study medium in
order to obtain metabolite starting concentrations.
5. Case study: the BHP2-7 cell line
In this tutorial, the BHP2-7 cell line is used as an example for
quantitative metabolome analysis. BHP2-7 is a cell line derived
from a papillary thyroid carcinoma (PTC), a differentiated type of
thyroid cancer [82]. PTC is themost common type of thyroid cancer,
around 70e80% of all thyroid cancers are of the PTC subtype with
an incidence rate of around 63,000 estimated new cases in the
United States for 2016 [83]. Genetic alteration in the Mitogen-
Associated Protein Kinase (MAPK) pathway are often found in
PTCs and are believed to be important events for tumor initiation,
progression and clinical outcome [84]. The most prevalent genetic
alteration in classic PTC is the V600E hotspot pathogenic variation
of BRAF followed by one of the (at least) 12 possible gene fusions
targeting the RET proto-oncogene (comprising. RET/PTC1-12). BRAF
and RET/PTC fusions are mutually exclusive [85]. The BHP2-7 thy-
roid cancer cell line is known to harbour a RET/PTC1 rearrangement
that subsequently leads to constitutively active MAPK signalling,
which in turn leads to metabolic changes that have been implicated
in metabolic syndromes such as type 2 diabetes and cancer [86].
5.1. Sampling BHP2-7 cells
BHP2-7 were cultured in 1:1 DMEM/F:12 medium, supple-
mented with 10% FBS. For these experiments, culturing was per-
formed without the addition of antibiotics. Furthermore, a HEPES-
free medium was acquired for quantitative NMR experiments. Cell
cultures were kept in T75 culture flasks and incubated at 37 C
under 5% CO2. Cultures were passed on when reaching around
80e90% confluence, which occurred roughly every three to four
days. Cultures were taken from the incubator and medium was
aspirated. Cultures were washed with 5 mL PBS at room tempera-
ture and 1 mL trypsin/EDTA was added and flasks were incubated
for 10 min to cause the cells to detach. Trypsin was neutralised by
the addition of 9 mL of fresh culture medium and cells were passed
on in a dilution of 1:20, meaning 9 mL of mediumwas added to the
flasks of which 0.5 mL was transferred to a 15 mL tube and spun
down (300  g, 3 min). The supernatant was removed from the cell
pellet and cells were re-suspended in 10 mL culture medium and
plated in a fresh T75 flask.
To perform the quantitative NMR study, cells were plated in
10 cm petri dishes instead of T75 culture flasks as they allow for
easier handling of the cell cultures for quenching and extraction. As
the surface area of the petri dish (78.54 cm2) is almost equal to that
of the T75 culture flasks (75 cm2), the same dilution of 1:20 was
used to plate the cells. The chosen dilution differs for each specific
cell line as each has a unique growth rate, but the used dilution
aims to generate a culture that shows 80e90% confluency after 72 h
in culture to circumvent any metabolic changes caused by
decreased proliferation due to contact inhibition. Optimal dilutions
should be determined experimentally for each individual cell line
before starting a large-scale experiment. Briefly, cells were de-
tached and trypsin neutralised by the addition of 9 mL of culture
medium. Cells were spun down (300  g for 3 min) and superna-
tant was removed after which a fresh cell suspension was made by
the addition of 10 mL culture medium. The suspension wascarefully homogenised and 0.5 mL pipetted in each petri dish. Petri
dishes were supplemented with 9.5 mL culture medium and the
cells were allowed to settle at room temperature for one hour
before placing them in the incubator.
5.1.1. Quenching and extraction of BHP2-7
0.3 mL of culture medium was aspirated from each sample and
mixed with 0.6 mL of 100% LC-grade cold MeOH (80 C) in a
microcentrifuge tube. The samples were then temporarily stored at
(80 C) until NMR analysis. The remaining culture medium in the
dish was quickly aspirated and cells were washed with 5 mL of
warm PBS (37 C). Culture medium removal and washing occurred
in less than 5 s. We subsequently quenched metabolism by snap-
freezing the cells with approximately 10 mL of lN2. After about
30 s when most of the lN2 had been evaporated, the culture dish
was placed on dry-ice until all remaining samples were quenched.
For the extraction of intracellular metabolites, 1.5 mL of cold
aqueous 90% MeOH/CHCl3, 9:1 (v/v) solution was added to each
culture dish and the cells were scraped using a cell lifter and
transferred to amicrocentrifuge tube. The extractionmixtures were
then centrifuged at 16000g at 4 C for 10 min. The supernatants
were collected in cryo-vials and stored at 80 C until analysis. The
extraction solvent was kept on dry-ice during the extraction of all
samples and the whole procedure was performed in a cold room
(4 C).
Although we usually recommend to carry out correction based
on protein content, we have found that cell numbers and protein
content correlate linearly. In turn, in some cases cell numbers can
also be used as correction parameter, with protein content being
preferred. However, the most important point in this context is
consistency. For this experiment cell numbers per sample were
estimated from cells cultured in parallel to the experiment. Cells
were collected after trypsin detachment and 10% of the cells were
taken up in 0.5 mL PBS and counted in a 20-fold dilution using a
fluorescence based Muse automated cell analyser. Approximately
2.45  107 cells per sample were extracted for this study.
5.1.2. NMR sample preparation
At the day of NMR analysis, culture medium samples were
centrifuged at 16000g at 4 C for 20 min and the protein-free
supernatants were collected. The same protocol was repeated for
cells-free culture medium in order to assess the composition of
nutrients. Since FBS can induce some variation to the composition
of the mediumwith regard to the one provided by the supplier, we
have also measured FBS-free DMEM/F12samples. Organic solvents
after extraction were removed under a gentle stream of nitrogen
(~2 h). Dried material was reconstituted with 250 mL of 0.15 M
phosphate buffer (pH ¼ 7.4; 0.15 M K2HPO4, 0.2 mM NaN3, and
0.4 mM TSP-d4) in D2O. Each sample was vortexed for 30 s and
transferred to a 96 well-plate. 165 mL of each sample was then
transferred to 3 mm NMR tubes using a Gilson 215 liquid-handler.
The NMR tubes were subsequently placed in a SampleJet with
cooling racks (6 C) and measured within the same day.
Leftovers (30 mL) from each sample after the addition of buffer
and transfer to NMR tubes, were pooled and aliquoted to cryo-vials
for temporary storage at 29 C. These pool samples were later
used for 2D NMR experiments and spectrometer optimization as
described in section 3.1.
5.1.3. NMR experiments
1H NMR data were obtained using a Bruker 600 MHz AVANCE II
spectrometer equippedwith a 5mmTCI cryo probe. The same set of
experiments were acquired for both cells extracts and culture
media samples. All 1H NMR spectra were recorded at 300 K with
presaturation (gB1/2p ¼ 50 Hz). Duration of 90 proton pulses was
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gated nutation experiment [87] on the locked and shimmed sam-
ples after automatic tuning andmatching of the probe head. For the
1D NOESY experiment, we collected 128 scans of 65536 points
covering 12335 Hz, using a relaxation delay of 4 s, acquisition time
of 2.72 s and mixing time of 10 ms. The free induction decays (FIDs)
were zero filled by a factor of two and Fourier transformed. All
spectra were automatically phase and baseline corrected and
referenced to the internal standard (TSP; d0.0159 ppm, for import
in Chenomx, see 4.2.1). 2D Jres were acquired with presaturation,
using the same pulse as for 1D NOESY. The relaxation delay was set
at 2 s and the spectral width was 16.66 ppm (12288 Hz) for the
direct dimension and 78 Hz for the indirect one and 4 scans were
acquired over 40 increments. The FIDs were automatically pro-
cessed with Fourier transformation, tilted by 45, symmetrized
around the direct dimension (F2) and calibrated using the TSP
signal at d 0.0159 ppm in the F2 dimension and at 0.0 Hz in the
indirect (F1) dimension. The total time of measurement was 24min
per sample, including 5 min for temperature stabilization, auto-
mation routines for tuning, matching, locking to deuterium fre-
quency, shimming and pulse calibration and the 1D NOESY and Jres
acquisition.
Additional 2D NMR spectrawere recorded to aid the assignment
of metabolites using pool samples. The set of 2D experiments
included 1He1H COSY, 1He1H TOCSY, 1He13C HSQC (edited to
provide information of carbon multiplicity) and 1He13C HMBC
using a low pass filter for one bond couplings. Presaturation for
water suppression (gB1/2p ¼ 50 Hz) was applied in all experiments.
The standard parameters implemented in Topspin 3.0 (Bruker
Biospin, Ltd.) were used for all experiments. All parameters used for
this study are provided in the supplementary material.
Prior to the automatic measurements of all samples, one pool
sample was used to optimize the instrumental parameters and
assess stability. The standard set of experiments was acquired right
after sample preparation, after 24 h left standing in the cooling rack
(6 C) of the SampleJet and after storage at 29 C for one week.
An additional set of measurements was performed, with sam-
ples from cells-free DMEM/F12 medium (without FBS). In this set,
each sample was measured with the experimental parameters
described above for 1D NOESY as well as with the METNOESY pulse
sequence and parameters suggested by Chenomx (supplementary
information). Briefly, METNOESY does not use pulse-field gradi-
ents and the repetition time is 5 s, split in 1 s of delay and pre-
saturation and 4 s of acquisition. The same receiver gain RG and 90
pulse was used in both experiments.
5.2. Analysis of NMR spectra
The 1D NOESY NMR spectra of BHP2-7 cell extracts exhibited a
reproducible profile, as seen confirmed by visual inspection of an
overlay of all spectra. This was also true for the TSP peak which was
identical in all spectra. We have also evaluated the stability of the
samples during 24 h kept at 6 C using multiple measurements of
the pool sample, immediately after sample preparation and after
24 h. These findings, indicate that sampling was consistent among
all samples and that samples are stable within a 24 h time window
when left standing at 6 C. Hence, we can assume that following
this experimental setting for more cell lines, the differences in
metabolic profiles can be attributed to true biological variation.
5.2.1. Spectra annotation
Metabolites were annotated with combined use of Bruker's
bbiorefcode and Chenomx NMR databases and analysis of the 2D
NMR spectra (Fig. 7). The IDs and exact chemical shifts of UDP-N-
acetyl glucosamine, UDP-glucuronate, UDP-glucose, N-acetylaspartate, and ATP were confirmed with spiking experiments
of the pure compounds. In total 65 intracellular metabolites were
identified in the cellular extracts of BHP2-7 and 45 metabolites in
the culture medium (Table 1). Fig. 7 depicts some characteristic
peaks from the majority of the intracellular metabolites (62 out of
65). The panel of identified compounds covers several classes like
amino acids, carbohydrates, nucleotides, amines, intermediates of
TCA cycle and other organic acids and co-factors. With regard to
culture medium analysis, we identified the majority of nutrients
provided by the manufacturer, with the exception of inorganic salts
and macromolecules. Moreover, additional compounds that were
excreted by the cells during growth, were also found (Table 1).
5.2.2. Quantification of metabolites
All identified molecules were quantified with Chenomx NMR
suite.Wemanaged to profile themajority of the NMR resonances in
the proton spectra of BHP2-7 with only a few exceptions of un-
knownpeaks that needed further verification. Although there is not
any theoretical or reference composition for cells extracts for us to
compare with our results, the experiment was performed with 8
biological replicates of one cell line. Therefore, if all steps (Fig. 1),
from cell culture, quenching and extraction, to the NMR measure-
ment and the quantification, had occurred perfectly, we should
obtain the exact same results for each extract. We used the coef-
ficient of variation as a measure of the method precision. Overall,
we obtained an average CV of 17.34% (median CV ¼ 14.82%).
Considering all steps of the workflow where an error could have
occurred, we conclude that the 8 extracts were overall a homoge-
neous group. Among all intracellular metabolites, asparagine,
ornithine, lysine, arginine, pyruvate, 2-oxoisocaproate, pyrogluta-
mate, lactate and D-glucose had the largest CV (>30%). D-glucose
occurs in two forms in solution (a and b), but Chenomx uses a
mixture of the two and, at least in our hands, the software cannot fit
all peaks correctly. On the other hand, we don't have an obvious
explanation for the large CV of lactate. The overlapped resonance of
threonine at d 1.33 ppm (Table 1) could be one reason, but it was
quantified with a lower CV (19.54%). The large variation for aspar-
agine and pyruvate could be a combination of the low level and the
overlap with other larger peaks, glutamate and glutathione,
respectively. Finally, for the other compounds with high CV, some
could be due to overlapped complex resonances and low levels
(ornithine, pyroglutamate and 2-oxoisocaproate) and due to over-
lapwith each other (lysine and arginine). On the other hand, we can
also see that several compounds quantified in the low mM range
(2.7e~20), like fumarate, N,N-dimethylglycine, NADþ, GTP, 1-
methylnicotinimide and UDP-N-acetylglucosamine exhibited low
CV (<10%) which means that the LOQ can be set to a low S/N, e.g.
the fumarate singlet had an average S/N of 6, in those cases of better
resolved resonances. It is also noteworthy, that ATP, which is known
to have fast turnover rates [33,34], was quantified with a CV of
14.82%, indicating a robust sampling procedure.
In order to assess the performance of BATMAN, we have also
quantified a subset of metabolites (Table 1; BATMAN values are
shown in parentheses). Among these metabolites, only isoleucine
lactate and ATP had a similar CV compared with Chenomx results.
With regard to the average concentrations, both methods were in
agreement for a-ketoglutarate, NADþ, isoleucine and fumarate, but
in all other cases, there were noticeable differences. To our view,
some compromises have to be made when working with BATMAN,
especially for those peaks that are partially masked by larger ones,
or those masking other smaller ones. Apart from that, the BATMAN
method can still provide quantitative information for a smaller set
of metabolites albeit with a lower precision.
As already mentioned, knowing the composition of the culture
media can be also of great importance. In some cases, the uptake
Fig. 7. Regions of the 600 MHz 1H NMR of BHP2-7 cells extract dissolved in deuterated phosphate buffer. The characteristic peaks from most of the identified metabolites (in total,
65) for this cell line are annotated with numbers. Keys: 1: Pantothenate; 2: Isoleucine; 3: 2-oxoisocaproate; 4: Leucine; 5: 3-methyl-2-oxovalerate; 6: Valine; 7: Lactate; 8: Lysine; 9:
Alanine; 10: Arginine; 11: Ornithine; 12: Acetate; 13: Proline; 14: N-acetylaspartate; 15: N-acetylglutamine; 16: Glutamate; 17: Glutamine; 18: Glutathione (GSH); 19: Pyruvate
(Oxalacetate); 20: Succinate; 21: Pyroglutamate; 22: Citrate; 23: Methionine; 24: Hypotaurine; 25: Malate; 26: Aspartate; 27: Asparagine; 28: a-ketoglutarate; 29: Creatine; 30:
Phosphocreatine; 31: Phenylalanine; 32: Histidine; 33: Choline; 34: O-phosphocholine; 35: sn-glycerophosphocholine; 36: D-glucose; 37: Taurine; 38: Betaine; 39: Trimethylamine-
N-oxide; 40: Myoinositol; 41: Methanol (residual solvent); 42: Hypotaurine; 43: Galactitol; 44: Glycine; 45: Fructose; 46: Galactose; 47: Threonine; 48: Serine; 49: ATP; 50:
Galactose-1-phosphate; 51: UDP-N-acetylglucosamine; 52: UDP-glucose; 53: UDP-glucuronate; 54: UMP; 55: NADþ; 56: Fumarate; 57: Tyrosine; 58: Tryptophan; 59: GTP; 60:
Nicotinate adenine dinucleotide; 61: Formate; 62: 1-methylnicotinamide; * overlapped peaks from D-glucose, D-galactose, Fructose, GSH and several amino acids (-CaH-).
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growth and physiology. To do this, the exact composition of the
starting culture medium has to be measured. Although, frequently
this information is provided by the supplier, it is strongly recom-
mended to perform in house analysis on the same platform used for
the other samples. In order to address these issues, we quantified
the DMEM/F12 medium, with and without 10% FBS. Our findings
are shown in Table 2. For this experiment, we have used the same
pulse sequence as the one for cell extracts (Prof-1, Table 2). Except
for the metabolites that were not listed but were detected and
quantified in our samples, it is apparent that the common nutrients
exhibited some rather large differences. For example, alanine and
glutamatewere found to be almost 4 timesmore abundant than the
supplier indicated, pantophenate 2.7 times and myo-inositol 2
times increased. On the contrary, arginine, histidine, hypoxanthine,
lysine, proline and pyruvate were found at lower levels than ex-
pected. These measurements were accompanied by an average CV
of 14.01%. Aiming to evaluate where this variation comes from, the
same medium was measured under the same condition but
without FBS. Overall, the CV was significantly reduced to 4.55%,
with only glutamate displaying a relatively large CV of 22.97%, but
some differences between the listed values and our data of the
quantification still remained. Although the deconvolution error for
some cases cannot be excluded, the relatively good precision of the
measurements, indicate a different type of error.
It was mentioned in section 3.2 that, at least according to thedeveloper, if Chenomx is used for quantification, then for the best
accuracy, the data should be collected with the METNOESY exper-
iment. In fact, no need for T1 relaxation times is needed in this case
and the absolute concentrations can be extracted. In order to
evaluate whether our 1D NOESY experiment provided data that
cannot be accurately fitted by Chenomx, we measured and quan-
tified the same samples using the METNOESYexperiments (Prof-2).
Overall, we obtained an average CV of 4.24% which was comparable
with Prof-1. More importantly, the two methods resulted in the
same results with only minor variation as it can be seen by the
ratios of Prof-1/Prof-2 in the last column of Table 2. We can safely
exclude the possibility of incorrect internal standard addition, if
this was the case, we should observe systematic variation between
the quantified and the listed values. However, some compounds
quantified by both methods were in agreement with the listed
values (e.g. arginine, glutamate (prof-2), glycine, histidine and even
the less concentrated hypoxanthine, among others). Based on these
findings, we conclude that the real composition of the culture
mediumwas to some extent different from the values given by the
supplier.
As a final note, we can conclude that the 1D NOESY-based
profiling, described in this tutorial, can be used with the Che-
nomx method for quantification. The data from the DMEM/F12
analysis show that only small variations should be anticipated be-
tween the two profiling experiments. Furthermore, due to the
gradients applied in the pulse sequence of the 1D NOESY
Table 2
Quantification of nutrients (mM) in DMEM, with and without 10% FBS and comparison with values given by the supplier. For the latter, the comparison of the two suggested
NMR profiling experiments is shown together with the CV (%). Prof-1 is the NOESY experiment we routinely use for metabolomics studies and Prof-2 is the METNOESY
experiment suggested by Chenomx NMR Suite. Supplier indicates the concentrations given by the supplier.
Metabolite supplier Prof-1a (DMEM-FBS) Prof-1 (DMEM) Prof-2 (DMEM) DMEM (1 vs 2)
mM mM CV (%) ratiob mM CV (%) ratiob mM CV (%) ratiob ratioc
Alanine 0.050 0.190 15.751 3.809 0.084 0.384 1.675 0.086 1.481 1.724 0.972
Arginine 0.699 0.567 7.227 0.811 0.720 5.315 1.029 0.695 15.263 0.994 1.035
Asparagine 0.050 0.053 12.923 1.064 0.069 4.555 1.380 0.073 5.492 1.458 0.947
Aspartate 0.050 0.057 19.050 1.147 0.064 2.385 1.273 0.069 4.106 1.375 0.926
Choline 0.064 0.080 14.958 1.255 0.085 2.642 1.330 0.084 1.437 1.307 1.017
Cystine 0.100 0.131 15.471 1.313 0.130 4.736 1.298 0.133 4.295 1.328 0.977
Glucose 17.506 14.555 11.068 0.831 16.995 2.139 0.971 16.951 3.784 0.968 1.003
Glutamate 0.050 0.187 10.879 3.734 0.065 22.972 1.299 0.054 5.998 1.071 1.213
Glutamine 2.500 2.092 13.302 0.837 2.306 0.764 0.923 2.332 2.114 0.933 0.989
Glycine 0.250 0.265 16.237 1.060 0.279 0.866 1.114 0.274 2.856 1.094 1.018
Histidine 0.150 0.119 16.350 0.792 0.156 2.815 1.040 0.147 0.915 0.981 1.060
Hypoxanthine 0.015 0.013 19.645 0.876 0.013 5.303 0.878 0.012 3.632 0.798 1.100
Isoleucine 0.416 0.399 13.286 0.959 0.473 0.476 1.138 0.481 0.499 1.157 0.983
Leucine 0.451 0.410 16.326 0.909 0.445 0.810 0.988 0.439 1.675 0.973 1.015
Lysine 0.499 0.435 11.938 0.872 0.496 7.354 0.995 0.482 1.658 0.967 1.029
Methionine 0.116 0.123 14.811 1.060 0.159 2.574 1.377 0.164 1.837 1.416 0.973
Niacinamide 0.017 0.017 6.381 1.027 0.023 3.030 1.395 0.021 2.028 1.240 1.125
Pantothenate 0.005 0.013 12.154 2.700 0.013 4.020 2.719 0.013 1.754 2.804 0.970
Phenylalanine 0.215 0.192 16.275 0.892 0.242 1.864 1.125 0.238 1.913 1.108 1.015
Proline 0.150 0.126 13.818 0.839 0.141 2.865 0.942 0.143 2.787 0.954 0.988
Pyridoxine 0.010 nd nd 0.003 11.945 0.297 0.003 5.149 0.304 0.978
Pyruvate 0.500 0.255 15.034 0.510 0.119 10.381 0.239 0.114 11.880 0.228 1.047
Serine 0.250 0.281 15.552 1.126 0.309 3.413 1.235 0.320 1.360 1.281 0.964
Threonine 0.449 0.436 14.535 0.970 0.518 2.528 1.153 0.520 2.574 1.158 0.996
Tryptophan 0.044 0.040 9.927 0.904 0.047 1.294 1.063 0.047 1.737 1.052 1.010
Tyrosine 0.214 0.200 13.588 0.935 0.252 1.810 1.180 0.248 1.310 1.161 1.016
Valine 0.452 0.450 14.374 0.995 0.499 0.992 1.105 0.491 1.054 1.087 1.017
myo-Inositol 0.070 0.158 16.972 2.252 0.076 6.610 1.082 0.073 2.849 1.044 1.036
Formate 0.025 11.843 0.005 7.188 0.005 8.479 1.105












a Prof-1: measured with the noesygppr1d; Prof-2: measured with the Chenomx suggested, METNOESY experiment.
b Ratio between quantified and supplier values.
c Ratio between prof-1 and prof-2 values.
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S/N are achieved compared to the METNOESY experiment. When
sensitivity is an issue, this is an important improvement to
consider. Overall, since the library of compounds in Chenomx
software was developed to result absolute concentrations with
accurate fitting, following the recommendation described in this
tutorial for sampling, analysis and quantification, it is feasible to
obtain a close to accurate representation of the cellular
metabolome.6. Concluding remarks
Liquid chromatography and gas chromatography coupled to MS
are the gold standard for targeted and untargeted metabolomics.
Nevertheless, several pitfalls particularly related to absolute
quantification (e.g. matrix effects, labelled standard materials,
ionization suppression) make NMR spectroscopy an ideal alterna-
tive. While NMR spectroscopy cannot reach the sensitivity of the
aforementioned techniques, its robustness and ease of obtaining(absolute) quantitative data without the need of having (labelled)
standard materials at hand are two major advantages. With the
here described protocol, more than 65 intra and extra-cellular
metabolites from diverse chemical classes can be quantified. The
quantitative analysis of small carboxylic acids, amino acids, TCA
cycle intermediates and even bile acids would require several
dedicated liquid chromatography and gas chromatography based
methods [88] not to mention intrinsic problems of the methods
such as ionization suppression for liquid based and metabolite
degradation for gas based separation techniques [89]. In conclu-
sion, if a NMR spectrometer and enough sample material are
available and expected metabolite concentrations are high enough
(mM range), in our experience, NMR spectroscopy is the most
straightforward way for obtaining absolute quantitative intra- and
extra-cellular metabolic data. Moreover, the now described pro-
tocols for quenching and extracting intra- and extra-cellular me-
tabolites can be applied to any subsequent analysis technique,
chromatography based, or not.
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